{
  "meta": {
    "title": "Biochemistry_Test",
    "url": "https://brainandscalpel.vercel.app/biochemistry-test-4d6992cf.html",
    "scrapedAt": "2025-11-30T12:48:35.560Z"
  },
  "questions": [
    {
      "text": "Approximately how many polymerase chain reaction (PCR) products are produced from a single template DNA molecule in a PCR reaction that continues for 30 cycles?",
      "choices": [
        {
          "id": 1,
          "text": "64"
        },
        {
          "id": 2,
          "text": "128,000"
        },
        {
          "id": 3,
          "text": "Approximately 1 million"
        },
        {
          "id": 4,
          "text": "Approximately 1 billion"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A <strong>PCR reaction</strong> that continues for <strong>30 cycles</strong> will produce <strong>approximately </strong><strong>1 billion</strong> PCR products <strong>from a single template DNA molecule.</strong></p>\n<p>Polymerase chain reaction (<strong>PCR) </strong>is a method of amplifying a target sequence of DNA. DNA sequences as short as 50 to 100 bp and as long as 10 kb can be amplified by PCR. The amplification is exponential.</p>\n<ul>\n<li>20 cycles provide amplification of 2<sup>20 </sup>= 10<sup>6</sup>  or 1 million copies</li>\n<li><strong>30 cycles </strong>provide an amplification of<strong> 2<sup>30 </sup>=10<sup>9</sup> or 1 billion copies</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2812",
      "difficulty": "hard"
    },
    {
      "text": "A 3-week-old baby presented with 2 episodes of fits. On examination, repetitive movements as if the baby was boxing and bicycling were noticed. His urine had a sweetish odor and was positive for the dinitrophenylhydrazine test. Blood concentrations of which of the following amino acids is relatively higher in the baby?",
      "choices": [
        {
          "id": 1,
          "text": "Valine"
        },
        {
          "id": 2,
          "text": "Isoleucine"
        },
        {
          "id": 3,
          "text": "Alloisoleucine"
        },
        {
          "id": 4,
          "text": "Leucine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The above clinical scenario with a <strong>positive urine dinitrophenylhydrazine test</strong> is suggestive of <strong>maple syrup urine disease </strong>(MSUD). The levels of <strong>leucine</strong> are higher than the other three amino acids.</p>\n<p>MSUD is an <strong>autosomal recessive</strong> disorder which occurs due to <strong>deficiency</strong> of&nbsp;<strong>branched-chain ketoacid dehydrogenase</strong>&nbsp;<strong>complex</strong>. This impairs the metabolism of branched-chain amino acids <strong>valine</strong>, <strong>leucine</strong>,&nbsp;<strong>isoleucine</strong> and <strong>alloisoleucine</strong>.&nbsp;These amino acids, particularly <strong>leucine</strong> and its metabolite accumulate in the blood, causing toxic effects on the brain.</p>\n<p>The affected child develops <strong>poor feeding</strong> and <strong>vomiting</strong>&nbsp;a few days after birth. There is a period of hypertonicity with a period of flaccidity in between. These appear as repetitive <strong>boxing</strong> and<strong> bicycling</strong> <strong>movements</strong>. The babies may also have <strong>hypoglycemia</strong>, but this is <strong>not corrected </strong>by the administration of <strong>glucose</strong>. The urine, sweat, and cerumen of the baby have a sweetish maple syrup-like odor.</p>\n<p>Laboratory investigations will show increased&nbsp;<strong>levels </strong>of <strong>branched-chain amino acids</strong>&nbsp;in the plasma and urine. <strong>Leucine</strong> levels are usually higher than isoleucine, valine, and alloisoleucine. Since the patient excretes ketoacids in the urine, the urine will be positive for the&nbsp;<strong>dinitrophenylhydrazine test</strong>.</p>\n<p class=\"p1\">Treatment involves controlled intake of branched-chain amino acids using commercially available formulas and judicious supplementation of isoleucine and valine. Very high levels of leucine are removed by <strong>hemodialysis</strong>.</p><hr><h3>Related Pearl: Maple syrup urine disease(MSUD)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/431a47e4c13446e19249e1e6d5459e66x1280x1324.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0329",
      "difficulty": "hard"
    },
    {
      "text": "An infant with abdominal distension, fever, and jaundice was brought to the pediatric OPD. On further evaluation, a diagnosis of an autosomal recessive disorder due to a defect in the enzyme fumarylacetoacetate hydrolase was arrived at. What is the likely disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatorenal tyrosinemia"
        },
        {
          "id": 2,
          "text": "Richner-Hanhart syndrome"
        },
        {
          "id": 3,
          "text": "Neonatal tyrosinemia"
        },
        {
          "id": 4,
          "text": "Hawkinsinuria"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The autosomal recessive disorder due to a defect in the enzyme fumarylacetoacetate hydrolase in a child with abdominal distension, fever and jaundice is&nbsp;associated with <strong>Hepatorenal&nbsp;tyrosinemia (Type 1 tyrosinemia or tyrosinosis).</strong>&nbsp;It is the most common type of tyrosinemia.&nbsp;</p>\n<p>There are three types of <strong>tyrosinemias</strong>:</p>\n<ul>\n<li>Type 1 (<strong>Hepatorenal tyrosinemia</strong>):\n<ul>\n<li>Defective enzyme:<strong> Fumaryl acetoacetate hydrolase</strong>&nbsp;</li>\n<li>Inherited as an autosomal recessive trait</li>\n<li>Clinical features: Liver failure, hypoglycemia, boiled cabbage odour in the urine, and mental retardation.&nbsp;</li>\n</ul>\n</li>\n<li>Type 2 (<strong>Oculocutaneous tyrosinemia/Richner-Hanhart syndrome)</strong>:\n<ul>\n<li>Defective enzyme<strong>: Tyrosine transaminase</strong>&nbsp;</li>\n<li>Clinical features: Palmoplantar keratosis, painful corneal erosions, photophobia, mental retardation are seen.&nbsp;</li>\n</ul>\n</li>\n<li>Type 3 <strong>(Neonatal tyrosinemia):&nbsp;</strong>\n<ul>\n<li>Defective enzyme:<strong> 4-Hydroxyphenylpyruvate dioxygenase&nbsp;</strong></li>\n<li>Clinical features: Normal liver function, developmental delay, seizures and intermittent ataxia are seen.</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Hawkinsuria\n<ul>\n<li>Defective enzyme:<strong> 4-Hydroxyphenylpyruvate dioxygenase&nbsp;</strong></li>\n<li>Inherited as an autosomal <strong>dominant</strong> trait</li>\n<li>Clinical features: Transient failure to thrive and metabolic acidosis in infancy&nbsp;</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Types of tyrosinemia  with deficient enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Disease</strong></div>\n</td>\n<td>\n<div><strong>Enzyme-deficient</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 1 (Hepatorenal, Hereditary tyrosinemia, Tyrosinosis)</div>\n</td>\n<td>\n<div>Fumarylacetoacetate hydrolase (FAAH)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 2 (Oculocutaneous)</div>\n</td>\n<td>\n<div>Tyrosine aminotransferase</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 3 (Neonatal tyrosinemia)</div>\n</td>\n<td>\n<div>4-Hydroxyphenylpyruvate dioxygenase (4-HPPD)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Hawkinsinuria</div>\n</td>\n<td>\n<div>Missense mutations in the gene for 4-HPPD</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9973",
      "difficulty": "medium"
    },
    {
      "text": "An adolescent boy presents with jaundice and tiredness. On investigation, his AST was 150 IU/L, ALT was 175 IU/L and bilirubin was 4.5mg/dl. Serum ceruloplasmin levels were found to be low. Which of the following minerals is used in the treatment of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Copper"
        },
        {
          "id": 2,
          "text": "Zinc"
        },
        {
          "id": 3,
          "text": "Magnesium"
        },
        {
          "id": 4,
          "text": "Molybdenum"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>An adolescent with jaundice, elevated AST, ALT and low serum ceruloplasmin likely has <strong>Wilson’s disease. Zinc</strong> is used in the <strong>treatment</strong> of this condition.</p>\n<p>Wilson’s disease is an autosomonal recessive disorder. It is charactered by mutations of the <strong>ATP7B gene</strong>, resulting in decreased biliary copper excretion and ceruloplasmin formation. The <strong>accumulation</strong> of <strong>copper</strong> leads to <strong>liver disease</strong>, hemolysis, a movement disorder neurologic disease, and/or psychiatric illness.</p>\n<p>Elemental <strong>zinc</strong> is commonly used as a <strong>maintenance</strong> therapy along with <strong>chelating agents.</strong> Zinc acts by <strong>blocking</strong> the <strong>intestinal absorption</strong> of <strong>copper</strong>. It can also be used as <strong>first-line</strong> therapy in <strong>pregnancy.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3529",
      "difficulty": "hard"
    },
    {
      "text": "A 20-year-old bodybuilder started a diet of raw eggs as a source of protein, following which he developed dermatitis, atrophic glossitis, and muscular pains. On investigation, he was diagnosed with a vitamin deficiency. Which of the following enzymes does not require this vitamin as a coenzyme?",
      "choices": [
        {
          "id": 1,
          "text": "Pyruvate carboxylase"
        },
        {
          "id": 2,
          "text": "Propionyl-CoA carboxylase"
        },
        {
          "id": 3,
          "text": "Carbamoyl phosphate synthetase"
        },
        {
          "id": 4,
          "text": "Methylcrotonyl-CoA carboxylase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario of features like dermatitis, atrophic glossitis, and muscle pain developing in an individual on a raw egg diet is suggestive of&nbsp;<strong>biotin deficiency</strong>, and carbamoyl phosphate synthetase is the enzyme that is not dependent on biotin.</p>\n<p>A protein called <strong>avidin</strong> is present in the <strong>egg white</strong>, which binds to biotin in the diet, making <strong>biotin unavailable</strong> for intestinal absorption. Avidin is heat labile, and boiling of the egg neutralizes its inhibitory activity. One molecule of avidin can bind with four molecules of biotin.</p>\n<p>Biotin deficiency is rare, except in individuals on prolonged total parenteral nutrition and those consuming raw eggs. Individuals with a biotin deficiency may develop features such as dermatitis, atrophic glossitis, hyperesthesia, muscle pain, anorexia, and hallucinations. Treatment is the administration of an injection of&nbsp;<strong>100&ndash;300 mg&nbsp;</strong>biotin.</p>\n<p>Biotin serves as a <strong>co-enzyme</strong> for several <strong>carboxylase enzymes</strong>:</p>\n<ul>\n<li><strong>Acetyl-CoA carboxylase</strong>\n<ul>\n<li>This enzyme adds CO<sub>2</sub> to acetyl CoA, forming malonyl CoA.</li>\n<li>It is the rate-limiting reaction in the biosynthesis of fatty acids</li>\n</ul>\n</li>\n<li><strong>Pyruvate carboxylase</strong>\n<ul>\n<li>Pyruvate + CO<sub>2</sub> +ATP &rarr; Oxaloacetate +ADP + Pi</li>\n<li>It provides oxaloacetate, which is the catalyst for the TCA cycle and is an important enzyme in gluconeogenesis.</li>\n</ul>\n</li>\n<li><strong>Propionyl CoA carboxylase</strong>\n<ul>\n<li>Propionyl CoA +CO<sub>2&nbsp;</sub>+ ATP &rarr; Methyl malonyl CoA + ADP + Pi</li>\n</ul>\n</li>\n<li><strong>Methylcrotonyl-CoA carboxylase</strong></li>\n</ul>\n<div class=\"page\" title=\"Page 550\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Biotin also plays a role in the regulation of the cell cycle.</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Biotin-independent</strong> reactions:</p>\n<ul>\n<li>Urea and pyrimidine synthesis, with <strong>carbamoyl phosphate synthetase</strong>&nbsp;as the stepping stone</li>\n<li>Addition of CO<sub>2</sub> to form C6 in the purine ring</li>\n<li>Conversion of pyruvate to malate by malic enzyme</li>\n</ul><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0751",
      "difficulty": "medium"
    },
    {
      "text": "Identify the components of the CRISPR-Cas9 gene editing tool.",
      "choices": [
        {
          "id": 1,
          "text": "Guide DNA and protease"
        },
        {
          "id": 2,
          "text": "Guide DNA and nuclease"
        },
        {
          "id": 3,
          "text": "Guide RNA and nuclease"
        },
        {
          "id": 4,
          "text": "Guide RNA and protease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The components of the CRISPR-9 gene-editing tool are <strong>guide RNA</strong> and <strong>Cas9 nuclease</strong>.</p>\n<p><strong>CRISPR-Cas9</strong>&nbsp;is a&nbsp;<strong>genome editing tool</strong>&nbsp;and this system enables select bacteria to respond to and eliminate invading genetic material.&nbsp;It uses guide RNA transcribed from <strong>CRISPR DNA</strong> (Clustered Regularly Interspersed Palindromic Repeats of DNA) and a <strong>Cas9</strong> (CRISPR-associated protein 9) nuclease.</p>\n<p>The guide RNA targets and binds to specific <strong>complementary sequences</strong> of <strong>DNA</strong> which are then cleaved by Cas9. Following cleavage of the targeted DNA sequence, the natural DNA repair process can be allowed to proceed or a new sequence can be inserted.</p>\n<p>This technique can be used for gene&nbsp;<strong>deletion</strong>, gene&nbsp;<strong>editing</strong>, gene visualization, and&nbsp;<strong>modulation</strong>&nbsp;of gene transcription.</p><p>The Nobel Prize in Chemistry 2020 was awarded jointly to <strong>Emmanuelle Charpentier </strong>and <strong>Jennifer&nbsp;A. Doudna</strong>&nbsp;for the development of the <strong>CRISPR/ Cas9 gene-editing system</strong>, which has for the first time enabled scientists to make precise changes in the long stretches of DNA.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8950",
      "difficulty": "medium"
    },
    {
      "text": "A 2-month-old infant is found to be hypotonic, with a high forehead, large anterior fontanelle, markedly separated cranial sutures, and hepatomegaly. Further investigations confirmed a diagnosis of the cerebro-hepato-renal syndrome. Which of the following biochemical findings would not be seen in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Elevated levels of very long chain fatty acids"
        },
        {
          "id": 2,
          "text": "Elevated plasma phytanic acid"
        },
        {
          "id": 3,
          "text": "Elevated plasmalogen content of phospholipids"
        },
        {
          "id": 4,
          "text": "Abnormal synthesis of bile acids"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In <strong>cerebro-hepato-renal syndrome</strong> or&nbsp;<strong>Zellweger syndrome,&nbsp;</strong>there is a <strong>decreased level </strong>of <strong>plasmalogens.</strong></p>\n<p>Zellweger syndrome is caused by mutations in the peroxins (<em>PEX</em>) family of genes. As a result of this, there is a defective transport of the proteins to the peroxisomes. It severely impairs the functions of peroxisomes, resulting in defective&nbsp;<strong>beta-oxidation</strong>&nbsp;of very-long-chain fatty acids (VLCFA), defective&nbsp;<strong>alpha oxidation</strong>, and impaired synthesis of bile acids and plasmalogens.</p>\n<p>The child presents with</p>\n<ul>\n<li><strong>Dysmorphic facial features</strong>&nbsp;like wide anterior fontanelles markedly separated cranial sutures, epicanthal folds, broad nasal bridge, hypoplastic supraorbital ridges, etc.</li>\n<li>Profound&nbsp;<strong>developmental delay,&nbsp;</strong>profound hypotonia with depressed deep tendon reflexes, neonatal seizures, and impaired hearing</li>\n<li>Calcific stippling of the epiphyses</li>\n<li>Renal cysts</li>\n<li>Hepatomegaly</li>\n</ul>\n<p>Biochemical findings will show:</p>\n<ul>\n<li>Accumulation of&nbsp;<strong>very-long-chain fatty acids, phytanic acid, </strong>and&nbsp;pipecolic acids</li>\n<li>Abnormalities of the synthesis of bile acids</li>\n<li>Marked reduction of plasmalogens</li>\n<li>Elevated levels of plasma phytanic acid</li>\n</ul>\n<p>There is no appropriate treatment for Zellweger syndrome. It is very severe, and infants rarely survive beyond six months of age.</p><hr><h3>Related Pearl: Types, Location and Properties of Fatty acid oxidation</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Types of Oxidation</strong></p>\n</td>\n<td>\n<p><strong>Location</strong></p>\n</td>\n<td>\n<p><strong>Properties</strong></p>\n</td>\n<td>\n<p><strong>Associated Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Beta oxidation</p>\n</td>\n<td>\n<p>Mitochondria</p>\n</td>\n<td>\n<p>A catabolic process by which two-carbons are cleaved from the fatty acid molecule and released as acetyl CoA starting from the carboxyl end.</p>\n<p>The chain is broken between the &alpha;(2) and&nbsp;&beta;(3) carbon.</p>\n<p>1 round of beta-oxidation yield 1FADH2, 1NADH, and 1 Acetyl CoA.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Alpha oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>The presence of the 3-methyl group of phytanic acid prevents degradation by beta-oxidation.</p>\n<p>The chain is broken between the terminal carboxyl group and &alpha;(2) carbon removing that carbon as CO2. The remaining chain is activated with CoA and then undergoes&nbsp;&beta;-Oxidation.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Classic Refsum's Disease</p>\n<p>Defective enzyme- Phytanoyl Coa hydroxylase.</p>\n<p>Clinical features include:</p>\n<p>Ichthyosis, Retinitis pigmentosa, Decreased vision, Peripheral neuropathy, Ataxia</p>\n<p class=\"p2\">&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Omega oxidation</p>\n</td>\n<td>\n<p>Endoplasmic Reticulum</p>\n</td>\n<td>\n<p>An alternative pathway to beta-oxidation occurs in microsomes.</p>\n<p>Involves the&nbsp;oxidation&nbsp;of the &omega; carbon (terminal methyl group) resulting in dicarboxylic acid.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Peroxisomal Beta oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>Very-long-chain fatty acids undergo preliminary &beta;-oxidation in peroxisomes up to&nbsp;octanoyl CoA.&nbsp;The shortened fatty acids undergo further &beta;-oxidation in the mitochondria.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Zellweger (cerebrohepatorenal) syndrome</p>\n<p>A rare inherited absence of peroxisomes in all tissues.</p>\n<p class=\"p2\">They accumulate C<span class=\"s1\">26</span>&mdash;C<span class=\"s1\">38 </span>polyenoic acids in brain tissue and also exhibit a generalized loss of peroxisomal functions. The disease causes severe neurologic symptoms, and most patients die in the first year of life.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0727",
      "difficulty": "hard"
    },
    {
      "text": "A group of scientists is studying a protein. They electrophorese the protein and transfer it to a membrane. The proteins are visualized by tagging them to specific antibodies. This procedure is called:",
      "choices": [
        {
          "id": 1,
          "text": "Southern blot"
        },
        {
          "id": 2,
          "text": "Eastern blot"
        },
        {
          "id": 3,
          "text": "Northern blot"
        },
        {
          "id": 4,
          "text": "Western blot"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The above procedure depicts <strong>Western blot technique. </strong>This technique is used to study <strong>protein molecules.&nbsp;</strong>The proteins undergo electrophoresis and then are transferred to a membrane. These proteins are then tagged with the specific antibodies and visualized.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bfa9b12230034df2b67394965b46cd00x800x431.PNG\" alt=\"Explanation Image\"><p><strong>Northern blot technique&nbsp;</strong>is used to detect <strong>RNAs.</strong> The RNAs are separated by electrophoresis and then transferred to a membrane and bound to radiolabelled probes.</p>\n<p><strong>Southern blot technique</strong> is used to detect <strong>DNAs</strong>. In this technique, DNA is extracted from the cells and is cleaved into many fragments using a restriction enzyme. The resulting fragments are separated based on the size using electrophoresis.&nbsp;The DNA fragments are then denatured and transferred to a nitrocellulose membrane for analysis. The DNA fragment of interest is then identified using the specific DNA probe.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/24d3d5c2c06c40fcb70dd551aeb62033x800x494.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0357",
      "difficulty": "easy"
    },
    {
      "text": "A 1-year-old child is brought to the pediatrician with complaints that the child does not crawl or sit, does not smile, and does not recognize the mother. During the examination, it is noted that the child has a very fair complexion, light color hair, smaller head circumference for age, growth, and developmental delay. The child has a mousey odor. Which of the following are used in the management of this condition?<div class='question-desc-html'><ol>\n<li>Pegvaliase</li>\n<li>Tyrosine restriction</li>\n<li>Large neutral amino acids</li>\n<li>Sapropterin dihydrochloride</li>\n<li>Taliglucerase alpha</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 4 only"
        },
        {
          "id": 2,
          "text": "1, 3, and 4"
        },
        {
          "id": 3,
          "text": "2, 3, and 5"
        },
        {
          "id": 4,
          "text": "1, 2, 3 and 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">The given clinical manifestations point to the diagnosis of <strong>phenylketonuria&nbsp;</strong>(PKU). Pegvaliase, large neutral amino acids, and sapropterin dihydrochloride are used in the management of this condition. Tyrosine supplementation is used, and not restriction.</p>\n<p>Phenylketonuria commonly occurs due to a defect in the enzyme&nbsp;<strong>phenylalanine hydroxylase, PAH (classic phenylketonuria)</strong>. Less commonly it can also occur due to a defect in the enzymes producing <strong>tetrahydrobiopterin</strong>. These defects result in the impaired conversion of phenylalanine to tyrosine. The patient develops clinical features due to elevated levels of phenylalanine metabolites and decreased levels of tyrosine.</p>\n<p>Clinical features&nbsp;</p>\n<ul>\n<li><strong>Intellectual disability</strong>, developmental delay, microcephaly, and seizures- due to accumulation of phenylalanine metabolites and decreased tyrosine.</li>\n<li class=\"p1\"><strong>Fair hair, light skin color,&nbsp;</strong>and&nbsp;<strong>blue eyes</strong>- Tyrosine is needed for the synthesis of melanin. Reduced levels of tyrosine lead to the decreased melanin synthesis.</li>\n<li class=\"p1\">The babies have a <strong>mousey odor</strong> due to the accumulation of phenylacetic acid.</li>\n</ul>\n<p>Laboratory investigations that are useful in the diagnosis are</p>\n<ul>\n<li>Blood levels of phenylalanine</li>\n<li><strong>Ferric chloride test</strong></li>\n<li><strong>Guthrie test</strong></li>\n<li><strong>Tandem mass spectrometry</strong></li>\n</ul>\n<p class=\"p2\"><strong>Management</strong></p>\n<p class=\"p2\">A&nbsp;<strong>diet low in phenylalanine</strong>&nbsp;and <strong>supplementation of tyrosine</strong> can prevent the mental retardation of PKU.<span class=\"Apple-converted-space\">&nbsp;The blood levels of phenylalanine are maintained between</span>&nbsp;<strong>2 and 6 mg/dL.</strong></p>\n<p class=\"p2\"><span class=\"Apple-converted-space\">Administration of <strong>large neutral amino acid</strong> supplementation are useful. T</span>yrosine, tryptophan, leucine, isoleucine, valine, methionine, histidine, and phenylalanine share the same transporter for transport through intestinal membrane and blood-brain barrier. Hence, these amino acids compete and prevent the transport of phenylalanine.</p>\n<p class=\"p2\"><strong>S</strong><span class=\"Apple-converted-space\"><strong>apropterin</strong> is&nbsp;</span>a synthetic form of BH<span class=\"s1\">4</span>, which acts as a cofactor in patients with residual PAH activity.&nbsp;</p>\n<p class=\"p2\"><span class=\"Apple-converted-space\"><strong>Pegvaliase</strong>&nbsp;is a phenylalanine ammonia-lyase (PAL), that converts phenylalanine to ammonia and trans-cinnamic acid.</span></p>\n<p class=\"p2\"><span class=\"Apple-converted-space\">Eliglustat, taliglucerase alpha, velaglucerase alpha, imiglucarase, miglustat are approved by FDA for Gaucher's disease treatment.</span></p>\n</div>\n</div><hr><h3>Related Pearl: Phenylketonuria</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1a79bc9a0618454db8f2bfa6916ae3bbx1280x1001.JPEG\" alt=\"Pearl Image\"><ol>\n<li>BH<sub>4</sub> - tetrahydrobiopterin (or sapropterin, a synthetic form of BH<sub>4</sub>)</li>\n</ol><hr><h3>Related Pearl: Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0328",
      "difficulty": "medium"
    },
    {
      "text": "A patient was advised to take green leafy vegetables as a natural dietary source of vitamin K. Which is the compound that acts as the source of vitamin K in these vegetables?",
      "choices": [
        {
          "id": 1,
          "text": "Menadiol diacetate"
        },
        {
          "id": 2,
          "text": "Menadione"
        },
        {
          "id": 3,
          "text": "Phylloquinone"
        },
        {
          "id": 4,
          "text": "Menaquinone"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The normal dietary source of vitamin K is <strong>phylloquinone</strong> or <strong>vitamin K1</strong>, found in green leafy vegetables.</p>\n<p>Vitamin K is a fat-soluble vitamin and its deficiency leads to bleeding disorders.</p>\n<p>Three compounds have the biological activity of vitamin K:</p>\n<ul>\n<li><strong>Phylloquinone (Vitamin K1)</strong> is the normal dietary source of Vitamin K that is found in <strong>green leafy vegetables</strong>.</li>\n<li><strong>Menaquinone</strong>&nbsp;<strong>(Vitamin K2)</strong>&nbsp;is synthesized by <strong>intestinal bacteria.</strong></li>\n<li><strong>Menadione (Vitamin K3)</strong>&nbsp;and&nbsp;<strong>menadiol</strong> <strong>diacetate</strong> are<strong> synthetic</strong> compounds that are metabolized to phylloquinone.</li>\n</ul><hr><h3>Related Pearl: Fat-soluble vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\"><strong>Vitamin</strong></td>\n<td rowspan=\"2\"><strong>Active form</strong></td>\n<td rowspan=\"2\"><strong>Deficiency</strong></td>\n<td rowspan=\"2\"><strong>Toxicity</strong></td>\n<td colspan=\"3\"><strong>Required dietary allowance</strong></td>\n</tr>\n<tr>\n<td>Children</td>\n<td>Male</td>\n<td>Female</td>\n</tr>\n<tr>\n<td>Vitamin A</td>\n<td>\n<p>Retinol</p>\n<p>Retinal</p>\n<p>Retinoic acid</p>\n</td>\n<td>\n<p>Night blindness, xerophthalmia,</p>\n<p>Acne, psoriasis,</p>\n<p>Impaired immunity</p>\n</td>\n<td>\n<p>Affects lysosomes</p>\n<p>Acute- pseudotumor cerebrii, exfoliative dermatitis</p>\n<p>Chronic-fractures</p>\n</td>\n<td>\n<p>390-630mcg (1-9 years)</p>\n<p>770-1000mcg (10-18 years)</p>\n</td>\n<td>1000mcg&nbsp;</td>\n<td>&nbsp;\n<p>Adult - 840mcg</p>\n<p>Pregnancy - 900mcg</p>\n<p>Lactation - 950 mcg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin D</td>\n<td>1,25-Dihydro-cholecalciferol</td>\n<td>\n<p>Children- Rickets</p>\n<p>Adults-osteomalacia</p>\n</td>\n<td>Calcinosis</td>\n<td>&nbsp;\n<p>400 IU (&lt;1 year)</p>\n<p>600 IU (&gt;1 year)</p>\n</td>\n<td>&nbsp;600 IU</td>\n<td>\n<p>Adult - 600 IU</p>\n<p>Pregnancy - 600 IU</p>\n<p>Lactation - 600 IU</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin E</td>\n<td>&alpha;-tocopherol</td>\n<td>\n<p>Hemolytic anemia,</p>\n<p>axonal degeneration,</p>\n<p>spinocerebellar ataxia</p>\n</td>\n<td>\n<p>Reduced platelet aggregation,&nbsp;</p>\n<p>Interferes with vitamin K</p>\n</td>\n<td>&nbsp;5-8 mg</td>\n<td>&nbsp;10 mg</td>\n<td>\n<p>Adult - 8 mg</p>\n<p>Pregnancy - 10 mg</p>\n<p>Lactation - 12 mg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin K</td>\n<td>\n<p>Menedione</p>\n<p>Menoquinone</p>\n<p>Phyloquinone</p>\n</td>\n<td>\n<p>Elevated prothrombin time and bleeding</p>\n<p>Haemorrhagic disease of newborn</p>\n</td>\n<td>\n<p>Hemolysis</p>\n<p>Hyperbilirubinemia</p>\n<p>Kernicterus</p>\n</td>\n<td>\n<p>&lt;1 year - 2-3&nbsp;&micro;g</p>\n<p>Children - 30-50&nbsp;&micro;g</p>\n&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note:The <strong>RDA</strong> for <strong>Vitamin D</strong> in the <strong>elderly</strong> (&gt;60 years) is <strong>800 IU</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0677",
      "difficulty": "easy"
    },
    {
      "text": "A child is brought to the doctor with severe agonizing, burning pain in the hands, feet, and proximal extremities. On examination, he also has telangiectatic skin lesions, particularly between the umbilicus and knees. The ophthalmic examination also reveals corneal opacity. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Fabry disease"
        },
        {
          "id": 2,
          "text": "Niemann-Pick disease"
        },
        {
          "id": 3,
          "text": "Gaucher disease"
        },
        {
          "id": 4,
          "text": "Tay-Sachs disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most likely diagnosis is <strong>Fabry disease.</strong></p>\n<p><strong>Fabry disease</strong>&nbsp;is an&nbsp;<strong>X-linked</strong>&nbsp;inborn error of glycosphingolipid metabolism because of deficient activity of&nbsp;<strong>&alpha;-galactosidase A </strong>enzyme. This enzyme deficiency leads to accumulations of neutral glycosphingolipids, primarily&nbsp;<strong>globotriaosylceramide</strong>, especially in the plasma and lysosomes of vascular endothelial and smooth muscle cells, cardiac myocytes, and renal podocytes. The features of Fabry disease include:</p>\n<ul>\n<li><strong>Angiokeratomas</strong>- telangiectatic skin lesions characteristically seen densest between the umbilicus and knees called the bathing trunk area</li>\n<li>Hypohidrosis - decreased sweating</li>\n<li><strong>Corneal&nbsp;</strong>and&nbsp;lenticular opacities (<strong>Cornea verticillata</strong>)</li>\n<li>Painful <strong>acroparesthesias</strong>&nbsp;</li>\n<li><strong>Fabry crises&nbsp;</strong>- severe agonizing pain in the hands, feet, and proximal extremities</li>\n<li>Urinary examination shows lipid inclusions with birefringent&nbsp;<strong>maltese cross</strong></li>\n</ul>\n<p>&nbsp;Given below is the image of <strong>cornea verticillata.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4d5861221eb74b53be6a81fd2764cab9x1200x719.JPEG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 3412\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"layoutArea\">Other options</div>\n<p>Option B-&nbsp;<strong>Niemann-Pick disease</strong> occurs due to the deficiency of <strong>sphingomyelinase.&nbsp;</strong>Affected children exhibit a combination of <strong>hepatosplenomegaly</strong>, developmental delay, reticular or nodular infiltration in the lungs, and <strong>retinal cherry-red spots.</strong></p>\n<p>Option C-&nbsp;<strong>Gaucher disease</strong> occurs due to the deficiency of&nbsp;<strong>&beta;-Glucosidase.&nbsp;</strong>It&nbsp;commonly has a combination of growth retardation, <strong>hepatosplenomegaly,</strong> thrombocytopenia, anemia, and <strong>Erlenmeyer flask deformity</strong> of the distal femur. Histology shows the presence of <strong>Gaucher cells</strong> which have a characteristic <strong>wrinkled-paper appearance</strong> resulting from the presence of intracytoplasmic substrate inclusions. The intelligence of the child is <strong>normal.</strong></p>\n<p>The below image shows <strong>Gaucher cells.</strong></p>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b15a11d8bfff41698cc4ad0f6534a475x720x632.PNG\" alt=\"Explanation Image\"><p>Option D-&nbsp;<strong>Tay-Sachs disease</strong> occurs due to a deficiency of <strong>hexosaminidase A</strong>. Affected children present with seizures, developmental delay, increased startle response, macrocephaly, and <strong>cherry-red spots</strong> in the eye. <strong>Hepatosplenomegaly&nbsp;</strong>is <strong>rare.</strong></p>\n<p><strong>Cherry red spots </strong>are commonly seen in Tay-Sachs disease, Sandhoff disease, generalized gangliosidoses, Niemann-Pick disease, metachromatic leukodystrophy, etc</p>\n<p>Below image- Cherry red spot</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8ce296c7ab54af8be9d8d3c020a44f2x720x538.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0377",
      "difficulty": "medium"
    },
    {
      "text": "What does the term folate trap refer to?",
      "choices": [
        {
          "id": 1,
          "text": "Accumulation of methyl tetrahydrofolate"
        },
        {
          "id": 2,
          "text": "Inhibition of dihydrofolate reductase"
        },
        {
          "id": 3,
          "text": "Folic acid toxicity"
        },
        {
          "id": 4,
          "text": "Synthesis of thymidine monophosphate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The term folate trap refers to <strong>accumulation of methyl tetrahydrofolate</strong> with deficiency of tetrahydrofolate. It is seen in <strong>vitamin B12 deficiency</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2340fa2f5ef54a51a74955f50a8b11cbx1280x1774.JPEG\" alt=\"Explanation Image\"><p><strong>Vitamin B12</strong> acts as a <strong>cofactor</strong> of methionine synthase, an enzyme involved in the regeneration of tetrahydrofolate from methyl-tetrahydrofolate. Hence, vitamin B12 deficiency leads to folate deficiency.</p>\n<p>Since vitamin B12 is also linked to regeneration of methionine from homocysteine, there is hyperhomocysteinemia as well. It increases the risk of atherosclerosis, hypertension and thrombosis.</p><hr><h3>Related Pearl: Active Forms and Functions of Water-Soluble Vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\">\n<p>Vitamin</p>\n</td>\n<td colspan=\"2\">\n<p>Coenzyme</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Name</p>\n</td>\n<td>\n<p>Function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B1(Thiamin)</p>\n</td>\n<td>\n<p>Thiamine pyrophosphate (TPP)</p>\n</td>\n<td>\n<p>Decarboxylation</p>\n<p>Transketolase reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B2(Riboflavin)</p>\n</td>\n<td>\n<p>Flavin-adenine-dinucelotide (FAD)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B3(Nicotinic acid, niacin)</p>\n</td>\n<td>\n<p>Nicotinamide-adenine dinucleotide(NAD<sup>+</sup>)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B5(Pantothenic acid)</p>\n</td>\n<td>\n<p>Coenzyme A</p>\n</td>\n<td>\n<p>Transfer of an acyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B6(Pyridoxine)</p>\n</td>\n<td>\n<p>Pyridoxal Phosphate(PLP)</p>\n</td>\n<td>\n<p>Transamination</p>\n<p>Decarboxylation</p>\n<p>Co-factor of glycogen phosphorylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B7(Biotin)</p>\n</td>\n<td>\n<p>Biotin</p>\n</td>\n<td>\n<p>Carboxylation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B9(Folic acid)</p>\n</td>\n<td>\n<p>Tetrahydrofolic acid (THFA)</p>\n</td>\n<td>\n<p>Donor of methyl/formyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B12(Cobalamin)</p>\n</td>\n<td>\n<p>Methylcobalamin and Adenosylcobalamin</p>\n</td>\n<td>\n<p>Co-factor of methionine synthase and methylmalonyl CoA mutase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C (Ascorbic acid)</p>\n</td>\n<td>Ascorbic acid and dehydroascorbic acid</td>\n<td>\n<p>Oxidation-reduction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9780",
      "difficulty": "easy"
    },
    {
      "text": "In a patient with jaundice which of the following tests can be used to determine serum bilirubin?",
      "choices": [
        {
          "id": 1,
          "text": "Ehrlich's test"
        },
        {
          "id": 2,
          "text": "Van den Bergh test"
        },
        {
          "id": 3,
          "text": "Hay's test"
        },
        {
          "id": 4,
          "text": "Benedict's test"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Van den Bergh test</strong> can be used to determine the <strong>serum bilirubin</strong> level in a patient with jaundice.</p>\n<p>Van den Bergh reaction is a <strong>colorimetric method</strong> to measure serum bilirubin. It is based on the formation of <strong>red-purple</strong> <strong>azodipyrroles</strong> when <strong>diazotized sulfanilic acid</strong> reacts with <strong>bilirubin</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Clinical condition</strong></td>\n<td><strong>Reaction with reagent</strong></td>\n<td><strong>Interpretation</strong></td>\n</tr>\n<tr>\n<td>Normal serum</td>\n<td>No reaction</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>High <strong>conjugated</strong> bilirubin<br />Eg: Obstructive jaundice</td>\n<td>Reacts in the absence of methanol</td>\n<td><strong>Direct</strong> positive</td>\n</tr>\n<tr>\n<td>High <strong>unconjugated</strong> bilirubin<br />Eg: Hemolytic anemia</td>\n<td>Reacts in the presence of methanol</td>\n<td><strong>Indirect</strong> positive</td>\n</tr>\n<tr>\n<td>High <strong>conjugated </strong>and<strong> unconjugated</strong> bilirubin<br />Eg: Hepatic jaundice</td>\n<td>Reacts strongly both with and without methanol</td>\n<td><strong>Biphasic</strong> reaction</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>Option A: <strong>Ehrlich's test </strong>is used to determine urinary and fecal<strong> </strong>urobilinogen.</p>\n<p>Option C: <strong>Hay's test </strong>is used for bile salts in the urine.</p>\n<p>Option D: <strong>Benedict's test</strong> is used to detect the presence of reducing sugars.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0751",
      "difficulty": "medium"
    },
    {
      "text": "A 68-year-old man came with complaints of long-standing arthralgia in the knee. On examination, bluish-black scleral patches were seen as shown. On further inquiry, he says that the urine turns black on exposure to air. Accumulation of which of the following compounds caused this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Benzoquinone acetate"
        },
        {
          "id": 2,
          "text": "Methyl malonyl CoA"
        },
        {
          "id": 3,
          "text": "Orotic acid"
        },
        {
          "id": 4,
          "text": "Sulfogalactosylceramide"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This clinical vignette is strongly suggestive of <strong>alkaptonuria </strong>and the pathological discoloration shown in the image is <strong>ochronosis. Accumulation </strong>of the compound <strong>benzoquinone acetate </strong>has caused this condition.</p>\n<p>Alkaptonuria is an <strong>autosomal recessive</strong> disorder of <strong>tyrosine</strong> metabolism, that develops due to the <strong>defect </strong>in<strong> homogentisate oxidase</strong>, the enzyme which oxidizes homogentisate to maleylacetoacetate. The defect in this enzyme will lead to the accumulation of homogentisic acid that  oxidizes into benzoquinone acetate. Later, benzoquinone acetate polymerizes and binds to tissues (especially collagen fibres).</p>\n<p>This oxidation process produces free radicals that cause tissue damage and incite inflammation. Additionally, the excess homogentisic acid is excreted in the urine. This results in the classical clinical features of alkaptonuria such as- </p>\n<ul>\n<li><strong>Homogentisic aciduria</strong>- <strong>Black discoloration </strong>of<strong> urine</strong> on prolonged <strong>exposure </strong>to<strong> air</strong> caused due to oxidation of the excreted homogentisate. </li>\n<li><strong>Ochronosis</strong>- <strong>Bluish-black discoloration</strong> of tissues mostly involving ear cartilage, ocular tissue, the skin of the eyelids, forehead, cheeks, and hands, nail beds, and even deeper structures such as the larynx and tendons.</li>\n<li><strong>Arthropathy</strong>- <strong>Debilitating arthralgia</strong> or arthritis that may be seen after the fourth or fifth decade.</li>\n</ul>\n<p>Other options-</p>\n<p>Option B- <strong>Methyl malonyl-CoA is </strong>seen in urine <strong>(methylmalonic aciduria) </strong>due to deficiency of<strong> methylmalonyl Co A</strong> <strong>mutase</strong> which is a vitamin b12 dependent enzyme.</p>\n<p>Option C- Increased <strong>orotic acid</strong> in the blood and urine is seen in <strong>ornithine transcarbamylase</strong> deficiency.</p>\n<p>Option D- <strong>Sulfogalactosylceramide</strong> is accumulated in <strong>metachromatic leukodystrophy</strong> due to deficiency of Aryl-sulfatase A.</p><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Color of urine  in different conditions</h3><p>Normal color of urine is <strong>pale straw</strong> due to presence of <strong>urochrome.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Cause</strong></td>\n</tr>\n<tr>\n<td>Smokey or cloudy</td>\n<td>\n<ul>\n<li>AGN</li>\n<li>Nephrotic syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Gross blood</td>\n<td>\n<ul>\n<li>Urological causes&nbsp; &nbsp; &nbsp;</li>\n<li>Nephro causes</li>\n<li>Hematological causes, e.g. PNH</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Red without blood [brownish tinge]</td>\n<td>\n<ul>\n<li>Rhabdomyolysis&nbsp; &nbsp;</li>\n<li>Beetroot ingestion&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Tea- or cola-colored urine</td>\n<td>Hemoglobinuria</td>\n</tr>\n<tr>\n<td>High-colored urine</td>\n<td>Bilirubinuria</td>\n</tr>\n<tr>\n<td>Darkens on standing</td>\n<td>Alkaptonuria</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;Due to Drugs:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality&nbsp;</strong></td>\n<td><strong>Drugs&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Orange</td>\n<td>\n<ul>\n<li>Rifamycins (rifampicin, rifabutin, rifapentine)</li>\n<li>B-complex&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Blue</td>\n<td>\n<ul>\n<li>Amitriptyline</li>\n<li>Methylene blue</li>\n<li>Copper poisoning</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Brown</td>\n<td>\n<ul>\n<li>Chloroquine</li>\n<li>Quinine</li>\n<li>Primaquine</li>\n<li>Nitrofurantoin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Yellow</td>\n<td>Tetracycline&nbsp;</td>\n</tr>\n<tr>\n<td>Pinkish</td>\n<td>Deferoxamine</td>\n</tr>\n<tr>\n<td>Green</td>\n<td>Triamterene</td>\n</tr>\n<tr>\n<td>Darkens on standing</td>\n<td>\n<ul>\n<li>Metronidazole</li>\n<li>Methyldopa</li>\n<li>Imipenem-cilastin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4b015c9fb0714bdd99bfe9f2af3ab6b8.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD8121",
      "difficulty": "medium"
    },
    {
      "text": "Match the vitamin deficiencies given in column A to their consequences given in column B.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Column A</strong></td>\n<td><strong>Column B</strong></td>\n</tr>\n<tr>\n<td>1. Folic acid</td>\n<td>a. Beriberi</td>\n</tr>\n<tr>\n<td>2. Vitamin B<sub>3</sub></td>\n<td>b. Neural tube defect</td>\n</tr>\n<tr>\n<td>3. Vitamin B<sub>1</sub></td>\n<td>c. Loose and bleeding gums</td>\n</tr>\n<tr>\n<td>4. Vitamin C</td>\n<td>d.&nbsp;dermatitis diarrhea, and dementia</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-b, 2-d, 3-a, 4-c"
        },
        {
          "id": 2,
          "text": "1-b, 2-a, 3-d, 4-c"
        },
        {
          "id": 3,
          "text": "1-c, 2-b, 3-a, 4-d"
        },
        {
          "id": 4,
          "text": "1-d, 2-c, 3-a, 4-b"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct match is&nbsp;<strong>1-b, 2-d, 3-a, 4-c.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Vitamins</strong></td>\n<td><strong>Coenzymes/ Active form</strong></td>\n<td><strong>Use</strong></td>\n<td><strong>Deficiency</strong></td>\n</tr>\n<tr>\n<td>Vitamin B<sub>1</sub> Thiamine</td>\n<td>Thiamine pyrophosphate</td>\n<td>\n<p>oxidative decarboxylation of pyruvate and &alpha;-ketoglutarate</p>\n<p>Transketolase</p>\n<p>Pyruvate dehydrogenase</p>\n</td>\n<td>\n<p>Beriberi</p>\n<p>Wernicke- Korsakoff syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B<sub>2</sub></p>\n<p>Riboflavin</p>\n</td>\n<td>\n<p>Flavin mononucleotide (FMN)</p>\n<p>Flavin adenine dinucleotide (FAD)</p>\n</td>\n<td>\n<p>NADH dehydrogenase</p>\n<p>Succinate dehydrogenase&nbsp;</p>\n</td>\n<td>&nbsp;\n<p>Dermatitis, cheilosis (fissuring at the corners of the mouth), and glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B<sub>3</sub></p>\n<p>Niacin</p>\n</td>\n<td>\n<p>Nicotinamide adenine dinucleotide (NAD<sup>+</sup>)</p>\n<p>nicotinamide adenine dinucleotide phosphate (NADP<sup>+</sup>)</p>\n</td>\n<td>\n<p>Oxidation reduction reactions</p>\n<p>Treatment of hyperlipidemia</p>\n</td>\n<td>Pellagra- dermatitis diarhhea, and dementia</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B5&nbsp; Pantothenic acid</p>\n</td>\n<td>Pantothenic acid</td>\n<td>\n<p>Succinyl CoA, fatty acyl CoA, and acetyl CoA</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Vitamin B<sub>6</sub> Pyridoxine</td>\n<td>Pyridoxal phosphate</td>\n<td>\n<p>Transamination</p>\n<p>Deamination</p>\n<p>Decarboxylation</p>\n<p>Deamination</p>\n</td>\n<td>Peripheral neuropathy</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin&nbsp;B<sub>7</sub></p>\n<p>Biotin</p>\n</td>\n<td>&nbsp;</td>\n<td>Carbon dioxide carrier for biotin dependant carboxylations</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B<sub>9</sub></p>\n<p>Folic acid&nbsp;</p>\n</td>\n<td>Tatrehydrofolate</td>\n<td>One carbon transfer</td>\n<td>&nbsp;\n<p>Megaloblastic anemia</p>\n<p>Neural tube defects</p>\n</td>\n</tr>\n<tr>\n<td>Cobalamine (B<sub>12</sub>)</td>\n<td>\n<p>Methylcobalamin</p>\n<p>5&prime; deoxyadenosyl cobalamin</p>\n</td>\n<td>Methylation</td>\n<td>Pernicious anemia<br />Subacute combined degeneration</td>\n</tr>\n<tr>\n<td>Vitamin C&nbsp;</td>\n<td>Ascorbic acid</td>\n<td>\n<p>Hydroxylation of prolyl and lysyl residues</p>\n<p>Antioxidant</p>\n</td>\n<td>Scurvy- loose spongy gums, loose teeth, swollen joints and hemorrhages&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Below image shows dermatitis seen in <strong>pellagra.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8c0a9800de0f40f5b25c42b0b81bcecfx720x521.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Active Forms and Functions of Water-Soluble Vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\">\n<p>Vitamin</p>\n</td>\n<td colspan=\"2\">\n<p>Coenzyme</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Name</p>\n</td>\n<td>\n<p>Function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B1(Thiamin)</p>\n</td>\n<td>\n<p>Thiamine pyrophosphate (TPP)</p>\n</td>\n<td>\n<p>Decarboxylation</p>\n<p>Transketolase reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B2(Riboflavin)</p>\n</td>\n<td>\n<p>Flavin-adenine-dinucelotide (FAD)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B3(Nicotinic acid, niacin)</p>\n</td>\n<td>\n<p>Nicotinamide-adenine dinucleotide(NAD<sup>+</sup>)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B5(Pantothenic acid)</p>\n</td>\n<td>\n<p>Coenzyme A</p>\n</td>\n<td>\n<p>Transfer of an acyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B6(Pyridoxine)</p>\n</td>\n<td>\n<p>Pyridoxal Phosphate(PLP)</p>\n</td>\n<td>\n<p>Transamination</p>\n<p>Decarboxylation</p>\n<p>Co-factor of glycogen phosphorylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B7(Biotin)</p>\n</td>\n<td>\n<p>Biotin</p>\n</td>\n<td>\n<p>Carboxylation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B9(Folic acid)</p>\n</td>\n<td>\n<p>Tetrahydrofolic acid (THFA)</p>\n</td>\n<td>\n<p>Donor of methyl/formyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B12(Cobalamin)</p>\n</td>\n<td>\n<p>Methylcobalamin and Adenosylcobalamin</p>\n</td>\n<td>\n<p>Co-factor of methionine synthase and methylmalonyl CoA mutase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C (Ascorbic acid)</p>\n</td>\n<td>Ascorbic acid and dehydroascorbic acid</td>\n<td>\n<p>Oxidation-reduction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0354",
      "difficulty": "easy"
    },
    {
      "text": "After a diet rich in cholesterol, it is seen that the de novo synthesis of cholesterol in the liver decreases. Which of the following enzymes is involved in this?",
      "choices": [
        {
          "id": 1,
          "text": "Acetoacetyl CoA synthase"
        },
        {
          "id": 2,
          "text": "HMG CoA lyase"
        },
        {
          "id": 3,
          "text": "HMG CoA synthase"
        },
        {
          "id": 4,
          "text": "HMG CoA reductase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the given options, the enzyme&nbsp;<strong>HMG CoA reductase</strong> is involved in the <strong>regulation </strong>of<strong> cholesterol synthesis</strong> in the body.</p>\n<div class=\"page\" title=\"Page 261\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>HMG-CoA</strong> is <strong>reduced</strong> to mevalonate by <strong>NADPH</strong> in a reaction catalyzed by <strong>HMG-CoA reductase</strong> which is the <strong>principal regulatory step</strong> in the pathway of cholesterol synthesis. It is the site of action of the cholesterol-lowering statins, which are HMG-CoA reductase inhibitors.</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Long-term regulation</strong> of cholesterol synthesis involves <strong>regulating</strong> the <strong>transcription</strong> of the gene for HMG CoA reductase. When there is <strong>sufficient cholesterol</strong> in the cell, <strong>transcription</strong> of the gene for HMG CoA reductase is <strong>suppressed</strong>, and there is <strong>decreased synthesis</strong> of cholesterol.&nbsp;</p>\n<p>When cholesterol is less, proteases in the Golgi bodies cleave a sterol regulatory element-binding protein (SREBP). The protein which is then formed binds to a sterol regulatory element (SRE) on the DNA. This activates transcription of the HMG CoA reductase gene which increases cholesterol synthesis.</p>\n<p>Hormones that influence HMG reductase are:</p>\n<ul>\n<li><strong>Insulin </strong>and<strong> thyroxine</strong> <strong>increase</strong> the activity of HMG CoA reductase</li>\n<li><strong>Cortisol </strong>and<strong> glucagon decrease</strong> the activity of HMG CoA reductase</li>\n<li><strong>Statins inhibit</strong> the activity of HMG CoA reductase</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/affadf70f6e14d269ed81f681a304e06x600x566.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A:<strong> </strong><span><strong>Acetoacetyl CoA synthase</strong> </span><span>catalyzes the reaction that combines two molecules of acetyl-CoA condense forming</span><strong> acetoacetyl-CoA</strong><span>.</span><span class=\"Apple-converted-space\">&nbsp;This acetoacetyl-CoA enters the cholesterol synthesis pathway along with a molecule of acetyl-CoA.</span></p>\n<p>Option B:&nbsp;<strong>HMG CoA lyase</strong> is involved in<strong> ketone body synthesis</strong> which converts HMG coA to acetoacetate.&nbsp;</p>\n<p>Option C: <strong>HMG CoA synthase</strong> catalyzes the reaction where the third molecule of acetyl CoA condenses with acetoacetyl CoA forming<strong> beta-hydroxy beta-methyl glutaryl CoA </strong>(<strong>HMG CoA</strong>).<strong>&nbsp;</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7087eb4a999a413da1c7e7c4a3566407x510x692.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0722",
      "difficulty": "medium"
    },
    {
      "text": "An 8-year-old girl presents with a red and pruritic rash on the sun-exposed areas of the body, along with a history of frequent falls, diarrhea, and dysentery. She was diagnosed with Hartnup disease. What causes these pellagra-like features in Hartnup disease?",
      "choices": [
        {
          "id": 1,
          "text": "Malabsorption of tryptophan"
        },
        {
          "id": 2,
          "text": "Deficiency of pyridoxal phosphate"
        },
        {
          "id": 3,
          "text": "Magnesium deficiency"
        },
        {
          "id": 4,
          "text": "Excessive loss of niacin in urine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Malabsorption of tryptophan</strong> leads to<strong> pellagra</strong> in Hartnup disease.</p>\n<p><span data-preserver-spaces=\"true\"><strong>Hartnup disease</strong>&nbsp;is an&nbsp;</span><strong><span data-preserver-spaces=\"true\">autosomal recessive</span></strong><span data-preserver-spaces=\"true\">&nbsp;condition caused by a&nbsp;</span><strong><span data-preserver-spaces=\"true\">defect&nbsp;</span></strong>in renal and intestinal<span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">transport&nbsp;</span>of tryptophan&nbsp;</strong>due to the mutation of the<strong><span data-preserver-spaces=\"true\">&nbsp;<em>SLC6A19</em> gene&nbsp;</span></strong>on chromosome 5<span data-preserver-spaces=\"true\">. As a result, the production of niacin from tryptophan is reduced, and this manifests as <strong>pellagra,</strong> with <strong>dermatitis,</strong> <strong>diarrhea,</strong>&nbsp;<strong>dementia,</strong> and glossitis. A characteristic skin rash called Casal&rsquo;s necklace may also be seen.</span></p>\n<p>Clinical features<span data-preserver-spaces=\"true\">&nbsp;include&nbsp;<strong>intermittent, reversible episodes</strong>&nbsp;affecting the skin and nervous system that are&nbsp;<strong>aggravated</strong>&nbsp;by sunlight, febrile illness, stress, and nutritional deficiency.&nbsp;<strong>Skin</strong>&nbsp;manifestations present after sun exposure and include erythematous, scaly patches, similar to&nbsp;<strong>pellagra</strong>.&nbsp;Neurologic&nbsp;manifestations include ataxia, tremor, mood disorder, depression, convulsions, and psychosis.</span></p>\n<p>Diagnosis<strong><span data-preserver-spaces=\"true\">&nbsp;</span></strong><span data-preserver-spaces=\"true\">is made by demonstrating the presence of&nbsp;<strong>neutral amino acids in the urine</strong>, thus distinguishing it from pellagra. Urine may also contain indican, which is produced as a by-product of tryptophan metabolism.&nbsp;</span></p>\n<p><strong>Casal&rsquo;s</strong> <strong>necklace</strong>:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b197a808894249d5a64384f538c86841x700x1019.JPEG\" alt=\"Explanation Image\"><p><strong>Niacin (Vitamin B3)</strong></p>\n<p>It is synthesized from the amino acid <strong>tryptophan</strong>. The active forms of niacin are&nbsp;<strong>nicotinic acid </strong>and <strong>nicotinamide. Nicotinamide&nbsp;</strong>is present in NAD and NADP, which are important for oxidation-reduction reactions and ADP ribosylation of proteins involved in the <strong>DNA repair mechanism.&nbsp;</strong>&nbsp;</p>\n<p>Deficiency of niacin causes <strong>pellagra</strong>. Important causes are as follows:</p>\n<ul>\n<li>Dietary deficiencies of niacin or tryptophan</li>\n<li>Hartnup disease- defective absorption of tryptophan</li>\n<li>Carcinoid syndrome- enterochromaffin cells increase the production of 5-hydroxytryptamine. This decreases the production of niacin.</li>\n</ul>\n<p>Excessive levels of niacin cause&nbsp;<strong>dilation of blood vessels</strong>, <strong>flushing,</strong> skin irritation, and liver damage.</p><hr><h3>Related Pearl: Conditions Associated with Pellagra-like Symptoms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Condition/Disease</strong></p>\n</td>\n<td>\n<p><strong>Reason for niacin deficiency</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hartnup disease</p>\n</td>\n<td>\n<p>Intestinal &amp; renal malabsorption of tryptophan</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoid syndrome</p>\n</td>\n<td>\n<p>Overproduction of serotonin that causes diversion of  tryptophan from NAD+ Pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 deficiency</p>\n</td>\n<td>\n<p>Defective kynureninase pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maize rich diet</p>\n</td>\n<td>\n<p>Niacin is in unavailable niacytin form</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Jowar diet (Sorghum)</p>\n</td>\n<td>\n<p>Increase leucine content inhibit QPRTase enzyme</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8949",
      "difficulty": "easy"
    },
    {
      "text": "An infant is brought to the pediatric OPD with clinical findings as shown in the image. Further examination shows that the child has a loss of developmental milestones, truncal hypotonia, and failure to thrive. Which of the following enzymes is defective in this child?",
      "choices": [
        {
          "id": 1,
          "text": "Branched chain keto-acid decarboxylase complex"
        },
        {
          "id": 2,
          "text": "Prolyl hydroxylase"
        },
        {
          "id": 3,
          "text": "Lysyl oxidase"
        },
        {
          "id": 4,
          "text": "Cystathionine synthase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given image reveals an infant with <strong>sparse </strong>and <strong>kinky hair.</strong> This, along with <strong>l</strong><strong>oss </strong>of <strong>developmental milestones</strong> and<strong> truncal hypotonia</strong>, strongly suggests a diagnosis of <strong>Menkes disease</strong>, which is caused by <strong>defective lysyl oxidase. </strong></p>\n<p>Menkes disease results from a deficiency of lysyl oxidase <strong>co-factor </strong>i.e<strong> copper. </strong>This is due to a defect in the <strong><em>ATP7A</em> gene,</strong> which prevents the absorption of copper from the intestine.</p>\n<p><strong>Note :</strong></p>\n<ul>\n<li>ATP7A mutation: Menkes disease - X-linked recessive</li>\n<li>ATP7B mutation: Wilson's disease - Autosomal recessive</li>\n</ul><hr><h3>Related Pearl: Menkes disease</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3f0c58fe358940b393c96afe12ef3455x1280x1951.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/cb48ea67190f4576a1cf5f9e0344a38f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6811",
      "difficulty": "medium"
    },
    {
      "text": "A patient diagnosed with carcinoid syndrome excretes a large amount of a certain metabolite of serotonin in the urine. Which enzyme is involved in the production of this metabolite?",
      "choices": [
        {
          "id": 1,
          "text": "Aminotransferase "
        },
        {
          "id": 2,
          "text": "PLP dependent amino acid decarboxylase"
        },
        {
          "id": 3,
          "text": "Monoamine oxidase"
        },
        {
          "id": 4,
          "text": "Tryptophan hydroxylase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In carcinoid syndrome, <strong>5-hydroxy indole acetic acid (5-HIAA)</strong> is excreted in large amounts in the urine<strong> </strong>and the enzyme <strong>monoamine oxidase</strong> is responsible for its production.</p>\n<p>A <strong>carcinoid tumor</strong> is a tumor of <strong>argentaffin cells</strong> that produces an <strong>excessive</strong> amount of <strong>serotonin</strong> and is characterized by cutaneous flushing, abdominal cramps, and diarrhea. Serotonin is a specialized product of <strong>tryptophan metabolism </strong>(as shown below).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2accede02d1e4ad7b92c6dffea20a10bx1280x1408.JPEG\" alt=\"Explanation Image\"><p>Urinary metabolites of serotonin in patients with carcinoid syndrome include N-acetylserotonin glucuronide and 5-hydroxy indole acetic acid. </p>\n<p>5-HIAA testing is a 24-hour urine test that is <strong>specific</strong> for <strong>carcinoid tumors</strong>. This test is the most common biochemical test for carcinoid tumors associated with carcinoid syndrome.</p>\n<p> Other options:</p>\n<p>Option A:<strong> Aminotransferase</strong> is involved in the conversion of GABA to Succinate.</p>\n<div class=\"page\" title=\"Page 226\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option B: <strong>PLP-dependent amino acid decarboxylase</strong> is involved in the second step of the synthesis of serotonin, where 5-hydroxy tryptophan is decarboxylated to 5-hydroxy tryptamine/serotonin.</p>\n<p>Option D: Tryptophan is first acted on by <strong>tryptophan hydroxylase</strong> in serotonin synthesis.</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Carcinoid syndrome</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/db331361dc434bed8535d417b2cfcb4fx1280x1845.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Neurotransmitter and Catabolic Enzymes</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Neurotransmitter&nbsp;</strong></td>\n<td><strong>Major enzymes&nbsp;</strong></td>\n<td><strong>Major final end product&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Epinephrine, norepinephrine, dopamine</td>\n<td>Monoamine oxidase, Catecholamine-o-methyltransferase&nbsp;</td>\n<td>Vanillyl mandelate(VMA)&nbsp;</td>\n</tr>\n<tr>\n<td>serotonin, dopamine</td>\n<td>Monoamine oxidase&nbsp;</td>\n<td>5-Hydroxy indole acetic acid(5-HIAA)&nbsp;</td>\n</tr>\n<tr>\n<td>Histamine&nbsp;</td>\n<td>Diamine oxidase, N-Methyltransferase&nbsp;</td>\n<td>Imidazoleacetic acid, N-methylimidazole-acetic acid&nbsp;</td>\n</tr>\n<tr>\n<td>GABA&nbsp;</td>\n<td>Aminotransferase&nbsp;</td>\n<td><strong>Succinate&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Acetylcholine</td>\n<td>&nbsp;Acetylcholine esterase</td>\n<td>&nbsp;choline</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Clinical importance:</strong></p>\n<p class=\"redesignmargintopadded\">5-HIAA testing is a 24-hour urine test that is&nbsp;<strong>specific to carcinoid tumors</strong>.&nbsp;This test is the most common biochemical test for carcinoid tumors associated with carcinoid syndrome.</p>\n<p class=\"redesignmargintopadded\">Symptoms like secretory diarrhoea and valvular heart disease in carcinoid syndrome are due to serotonin.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0662",
      "difficulty": "hard"
    },
    {
      "text": "Match the type of hyperlipoproteinemias in column A with the underlying defects present in column B. (LDL-low-density lipoprotein, VLDL- very low density lipoprotein)<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>Column A</td>\n<td>Column B</td>\n</tr>\n<tr>\n<td>1. Type I</td>\n<td>a.&nbsp;Defective LDL receptors</td>\n</tr>\n<tr>\n<td>2. Type IIa</td>\n<td>b. Overproduction of VLDL</td>\n</tr>\n<tr>\n<td>3. Type III</td>\n<td>c. Hepatic lipase deficiency</td>\n</tr>\n<tr>\n<td>4. Type IV</td>\n<td>d. Defective apo E</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>e. Lipoprotein lipase or Apo C-II deficiency</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-e, 2-a, 3-d, 4-b"
        },
        {
          "id": 2,
          "text": "1-b, 2-a, 3-d, 4-c"
        },
        {
          "id": 3,
          "text": "1-c, 2-b, 3-a, 4-e"
        },
        {
          "id": 4,
          "text": "1-d, 2-b, 3-c, 4-a"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct match is&nbsp;<strong>1-e, 2-a, 3-d, 4-b.&nbsp;</strong></p>\n<table>\n<tbody>\n<tr>\n<td>Column A</td>\n<td>Column B</td>\n</tr>\n<tr>\n<td>1. Type I</td>\n<td>e. Lipoprotein lipase or Apo C-II deficiency</td>\n</tr>\n<tr>\n<td>2. Type IIa</td>\n<td>a.&nbsp;Defective LDL receptors</td>\n</tr>\n<tr>\n<td>3. Type III</td>\n<td>d. Defective apo E</td>\n</tr>\n<tr>\n<td>4. Type IV</td>\n<td>b. Overproduction of VLDL</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\"><strong>Dyslipoproteinemias</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td colspan=\"3\"><strong>Hypolipoproteinemias&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Name</strong></td>\n<td><strong>Defect</strong></td>\n<td>\n<p class=\"p1\"><strong>Features</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Abeta</strong>lipoproteinemia</td>\n<td><strong>Defective loading</strong> of <strong>apo B</strong> with lipid</td>\n<td>\n<p class=\"p1\">No chylomicrons, VLDL, or LDL formation</p>\n<p class=\"p1\"><span class=\"Apple-converted-space\">Intestinal Malabsorption</span></p>\n<p class=\"p1\"><span class=\"Apple-converted-space\">Treated by administration of large doses of vitamin E.&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p2\">Familial &alpha;-lipoprotein deficiency<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p class=\"p2\">Tangier disease<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p class=\"p2\">Fish-eye disease<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p class=\"p3\">Apo A-I deficiencies<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td>Low or near absent HDL is seen in all&nbsp;</td>\n<td>\n<p>Hypertriacylglycerolemia</p>\n<p><span class=\"Apple-converted-space\">Low LDL</span></p>\n<p><span class=\"Apple-converted-space\">Atherosclerosis</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\"><strong>Hyperlipoproteinemias</strong></td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Familial lipoprotein lipase deficiency (<strong>type I)</strong><span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td>Defect in <strong>lipoprotein lipase</strong> or apo <strong>C-II</strong></td>\n<td>\n<p>Increased chylomicrons and VLDL</p>\n<p>Low LDL and HDL</p>\n<p>No increased risk of coronary artery disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Familial hypercholesterolemia (<strong>type IIa</strong>)<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td>Defective <strong>LDL receptors</strong></td>\n<td>\n<p class=\"p1\">Elevated LDL levels and hypercholesterolemia, resulting in atherosclerosis and coronary disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Familial <strong>type III</strong> hyperlipoproteinemia (broad &beta;-disease, remnant removal disease, familial dysbetalipoproteinemia</p>\n</td>\n<td>Defective <strong>apo E</strong></td>\n<td>\n<p>Increased chylomicrons and VLDL remnants.</p>\n<p class=\"p1\">Hypercholesterolemia, xanthomas, and atherosclerosis are seen</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Familial hypertriacylglycerolemia (<strong>type IV</strong>)</p>\n</td>\n<td><strong>Overproduction</strong> of <strong>VLDL</strong></td>\n<td>\n<p>Increased VLDL and cholesterol levels</p>\n<p class=\"p1\">Commonly associated with coronary heart disease, type 2 diabetes mellitus, obesity, alcoholism, and administration of progestational hormones.<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>Hepatic lipase deficiency</td>\n<td>\n<p class=\"p1\">Accumulation of large triacylglycerol-rich HDL and VLDL remnants.<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td>Xanthomas and coronary artery disease</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Familial hyperalphalipoproteinemia<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td>&nbsp;Increased HDL</td>\n<td>Beneficial condition, but rare&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Familial Dyslipidemias</h3><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Lipoprotein: Types, Sources and Action</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoproteins</strong></p>\n</td>\n<td>\n<p><strong>Source</strong></p>\n</td>\n<td>\n<p><strong>Action</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>Derived from intestinal absorption of triacylglycerol and other lipids</p>\n</td>\n<td>\n<p>Carry exogenous/dietary triacylglycerol from the intestine to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Very low density lipoproteins (VLDL)</p>\n</td>\n<td>\n<p>Derived from the liver</p>\n</td>\n<td>\n<p>Carry endogenous triacylglycerol from the liver to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low-density lipoproteins (LDL)</p>\n</td>\n<td>\n<p>Derived from VLDL</p>\n</td>\n<td>\n<p>Involved in cholesterol transport</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Highdensity lipoproteins (HDL)</p>\n</td>\n<td>\n<p>Derived from Liver, intestine, VLDL, chylomicrons</p>\n</td>\n<td>\n<p>Involved in reverse cholesterol &amp; Phospholipids transport and also in VLDL and chylomicron metabolism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Intermediate density lipoproteins(IDL)</p>\n</td>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>Triacylglycerol &amp; cholesterol transport</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Distribution of  Various Apolipoproteins on Lipoproteins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons remnants</p>\n</td>\n<td>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IDL</p>\n</td>\n<td>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL</p>\n</td>\n<td>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HDL</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre- &beta;- HDL</p>\n</td>\n<td>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0332",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following pathway is the most important source of reducing equivalents for fatty acid synthesis in the liver?",
      "choices": [
        {
          "id": 1,
          "text": "Glycolysis"
        },
        {
          "id": 2,
          "text": "Tricarboxylic acid cycle"
        },
        {
          "id": 3,
          "text": "Uronic acid pathway"
        },
        {
          "id": 4,
          "text": "Hexose monophosphate shunt pathway"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The reducing equivalent for fatty acid synthesis in the liver is <strong>NADPH</strong>. The <strong>most important</strong> source of <strong>NADPH</strong> is the <strong>hexose monophosphate shunt </strong>(HMP)<strong> pathway.</strong></p>\n<p>The HMP shunt pathway, or <strong>pentose phosphate pathway</strong>, is an alternative route for the metabolism of glucose. It generates <strong>NADPH</strong> and synthesizes<strong> ribose</strong>. NADP+ is hydrogenated to NADPH by <strong>glucose-6-phosphate dehydrogenase</strong>. Since the HMP shunt pathway and de novo fatty acid synthesis both occur in the <strong>cytosol</strong> of the cell, there are no membranes or permeability barriers against the transfer of NADPH. Thus, this forms the major source for NADPH for fatty acid synthesis. </p>\n<p>Other minor sources of NADPH are extramitochondrial isocitrate dehydrogenase and NADP malate dehydrogenase (malic enzyme). </p><hr><h3>Related Pearl: Reducing Equivalents and Their Uses</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Reducing agents</p>\n</td>\n<td>\n<p>Uses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NADPH</p>\n</td>\n<td>\n<p>Lipid synthesis</p>\n<p>Cholesterol synthesis&nbsp;</p>\n<p>Fatty acid chain elongation</p>\n<p>Cytochrome P450&nbsp;hydroxylation&nbsp;of&nbsp;aromatic compounds, steroids,&nbsp;alcohols, and&nbsp;drugs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NADH</p>\n</td>\n<td>\n<p>Metabolizes alcohol</p>\n<p>Glycolysis &amp; Krebs cycle</p>\n<p>Oxidative phosphorylation</p>\n<p>&beta;- Oxidation of fatty acid</p>\n<p>Catalyzes reactions in muscle and liver cells</p>\n<p>Electron Transport Chain</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FADH<sub>2</sub></p>\n</td>\n<td>\n<p>Krebs cycle</p>\n<p>Electron Transport Chain</p>\n<p>Oxidative Phosphorylation</p>\n<p>Cytochrome P450 hydroxylase cycle</p>\n<p>&beta;-Oxidation of fatty acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9932",
      "difficulty": "easy"
    },
    {
      "text": "A 2-year-old male child has delayed developmental milestones and intellectual disability, with the following appearance (image A). On further examination, there is an enlarged tongue, cloudy cornea, and hepatomegaly. A radiograph of the hand is shown in image B. A girl born in their family also had similar symptoms and she died at 9 years of age. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Scheie syndrome"
        },
        {
          "id": 2,
          "text": "Hurler-Scheie syndrome"
        },
        {
          "id": 3,
          "text": "Hurler syndrome"
        },
        {
          "id": 4,
          "text": "Hunter syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most likely diagnosis is <strong>Hurler syndrome. </strong>The child is <strong>2 years</strong> of age and has <strong>coarse facial features</strong> like a depressed nasal bridge, thick lips, and an open mouth with protruded tongue. The radiograph shows <strong>enlarged diaphyses</strong> of the metacarpals and phalanges. These features along with severe <strong>developmental delay</strong>, <strong>cloudy cornea</strong>, hepatomegaly, and<strong> intellectual disability</strong> suggest that the child has Hurler syndrome.</p>\n<p>It is a <strong>severe</strong> type of mucopolysaccharidoses <strong>(MPS) I</strong>. It is caused due to deficiency of <strong>α-L-iduronidase. </strong>This enzyme is required for the breakdown of dermatan and heparan sulfate. The deficiency of the enzyme leads to the accumulation of these mucopolysaccharides. </p>\n<p>Patients usually present between <strong>6-24 months</strong> of age. They have</p>\n<ul>\n<li><strong>Intellectual disability</strong></li>\n<li><strong>Skeletal dysplasia,</strong> called dysostosis multiplex- thick ribs, ovoid vertebral bodies,<strong> enlarged diaphyses</strong> of the long bones, macrocephaly, enlarged <strong>J-shaped sella</strong></li>\n<li><strong>Cloudy cornea</strong>, glaucoma, retinal degeneration</li>\n<li>Mixed hearing loss, etc</li>\n</ul>\n<p>Other options</p>\n<p>Option A- The <strong>Scheie syndrome</strong> is a milder form of MPS-I (MPS I-S ). The symptoms appear <strong>after 5 years</strong> of age and the diagnosis is made between 10-20 years. It is characterized by <strong>normal intelligence</strong> and stature, joint stiffness, aortic valve disease, corneal clouding, and mild dysostosis multiplex. Ophthalmic and cardiac involvement might be present.</p>\n<p>Option B- <strong>Hurler-Scheie syndrome</strong> is an intermediate between Hurler syndrome and Scheie syndrome. The onset of symptoms is between <strong>3-8 years of</strong> age. They have <strong>mild</strong> or <strong>no intellectual dysfunction</strong>. Ophthalmic and cardiac involvement might be present.</p>\n<p>Option D- <strong>Hunter syndrome</strong> is a <strong>type II MPS. </strong>It occurs due to the deficiency of <strong>iduronate 2-sulfatase. </strong>It shares the same features as type I MPS like coarse facial features, short stature, and dysostosis multiplex. However, there is <strong>no corneal clouding. </strong>It is the only MPS with <strong>X-linked recessive</strong> inheritance. So if a baby girl is affected in the family, it is less likely to be Hunter syndrome. All the other MPS are autosomal recessive.</p><hr><h3>Related Pearl: MPS and Their Respective Enzyme Deficiencies</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br />Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>&alpha;-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br />Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br />coarse facial features,&nbsp;<br />Hepatosplenomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br />Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br />Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>&alpha;-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>&alpha;-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br />short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>&beta;-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curvature of the spine,<br />Short stature<br />Skeletal dysplasia<br />Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>&beta;-glucuronidase</td>\n<td>Dermatan sulfate<br />Heparan sulfate<br />Chondroitin 4-sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;<br /><br /></td>\n<td>Short stature<br />Skeletal dysplasia<br />Hepatomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br />Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Diseases due to glycoprotein defect</h3><table>\n<tbody>\n<tr>\n<td><strong>Diseases</strong></td>\n<td><strong>Defect</strong></td>\n<td><strong>Characteristics</strong></td>\n</tr>\n<tr>\n<td>I-cell disease</td>\n<td>Mutation in GNPTA gene leading to a deficiency in enzyme UDP-N-acetylglucoseamine-1-phosphotransferase</td>\n<td>\n<ul>\n<li>Coarse facial features</li>\n<li>Corneal erosion</li>\n<li>Failure to thrive</li>\n<li>Hepatomegaly</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Leukocyte adhesion deficiency, type II</td>\n<td>Mutations affecting activity of Golgi-located GDP-fucose transporter </td>\n<td>\n<ul>\n<li>Neutrophil rolling</li>\n<li>Life-threatening, recurrent bacterial infections</li>\n<li>Psychomotor and mental retardation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Paroxysmal nocturnal hemoglobinuria</td>\n<td>Genetic mutation leading to the inability to synthesize the glycosyl-phosphatidylinositol (GPI) anchor that binds certain surface proteins to cell membranes.</td>\n<td>\n<ul>\n<li>Lysis of red cells</li>\n<li>Abdominal pain</li>\n<li>Back pain</li>\n<li>Esophageal spasms</li>\n<li>Erectile dysfunction</li>\n<li>Fatigue</li>\n<li>Progressive chronic renal failure</li>\n<li>Thrombophilia</li>\n<li>Bone marrow failure</li>\n<li>Venous thrombosis</li>\n<li>Aplastic anemia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Ehlers–Danlos syndrome</td>\n<td>Deficiency or mutation in Lysyl hydroxylase-1  </td>\n<td>\n<ul>\n<li>Neonatal kyphoscoliosis</li>\n<li>Generalized joint laxity</li>\n<li>Skin fragility</li>\n<li>Severe muscle hypotonia at birth</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Oligosaccharidoses</td>\n<td>Lack of a specific lysosomal hydrolase for glycoproteins</td>\n<td>\n<ul>\n<li>Delay in intellectual and physical development.</li>\n<li>Seizure</li>\n<li>Joint stiffness and pain</li>\n<li>Problems with vision and hearing</li>\n<li>Anaemia, nose bleeds, and easy bleeding or bruising</li>\n<li>Swollen abdomen due to enlarged spleen or liver. </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Congenital disorders of glycosylation  </td>\n<td>Glycosylation of a variety of tissue proteins and/or lipids is deficient or defective</td>\n<td>\n<ul>\n<li>Fatal, malfunction of several different organ systems</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Familial tumoral calcinosis (FTC)</td>\n<td>UDP-GalNAc transferase 3</td>\n<td>\n<ul>\n<li>Calcium deposits in skin and subcutaneous tissues</li>\n<li>Unresponsiveness to parathyroid hormone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Walker–Warburg syndrome (WWS)</td>\n<td>Defective α-dystroglycan</td>\n<td>\n<ul>\n<li>Agenesis of corpus callosum</li>\n<li>Anal atresia</li>\n<li>Atresia of the external auditory canal</li>\n<li>Blindness</li>\n<li>Buphthalmos</li>\n<li>Cerebellar dysplasia</li>\n<li>Cleft upper lip</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hereditary erythroblastic multinuclearity with positive acidified serum lysis test (HEMPAS)</td>\n<td>Defects in alpha–mannosidase II</td>\n<td>\n<ul>\n<li>Ineffective erythropoiesis</li>\n<li>Haemolysis &amp; erythroblast morphological abnormalities</li>\n<li>Hypoglycosylation of some red blood cell (RBC) membrane proteins</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/706b53faa52e4639a902467c9428a45c.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0353",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following enzymes are involved in gluconeogenesis?<div class='question-desc-html'><ol>\n<li>Pyruvate carboxylase</li>\n<li>Phosphoenol pyruvate kinase</li>\n<li>Hexokinase</li>\n<li>Pyruvate kinase</li>\n<li>Glucose 6 phosphatase</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2 and 5"
        },
        {
          "id": 2,
          "text": "2 and 3"
        },
        {
          "id": 3,
          "text": "1 and 5"
        },
        {
          "id": 4,
          "text": "1, 2 and 3"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Pyruvate carboxylase</strong> and <strong>glucose-6-phosphatase</strong> are enzymes used in gluconeogenesis. These enzymes catalyze <strong>irreversible steps</strong> of gluconeogenesis.</p>\n<p><strong>Glycolysis </strong>and<strong> gluconeogenesis</strong> are 2 metabolic pathways in <strong>opposite directions</strong> (glucose being the substrate and product respectively). The reversible enzymes are common in both pathways. But a few reactions are <strong>not reversible</strong> in glycolysis. So a different pathway is used or a different enzyme is used by the body to make the reactions feasible.</p>\n<p>At the start of gluconeogenesis, <strong>pyruvate carboxylase </strong>(Option 1) catalyzes the synthesis of oxaloacetate from pyruvate following which <strong>phosphoenolpyruvate carboxykinase </strong>converts it to phosphoenolpyruvate (not phosphoenol pyruvate kinase as in Option 2). Alternatively, at the end of glycolysis, the reverse of this reaction occurs in a single step catalyzed by <strong>pyruvate kinase</strong> (Option 4).</p>\n<p>At the end of gluconeogenesis, <strong>glucose 6 phosphatase</strong> (Option 5) converts glucose-1-phosphate to free glucose and is an irreversible process. Alternatively, glycolysis starts with the phosphorylation of glucose to glucose-6-phosphate by <strong>hexokinase</strong> (Option 3).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ab6287d4c3344460a3cda715d9451c74x600x1200.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Irreversible enzymes in gluconeogenesis pathway</h3><p>The&nbsp;enzymes can be remembered using the mnemonic <strong>P</strong>athway <strong>P</strong>roduces <strong>F</strong>resh <strong>G</strong>lucose.</p>\n<table>\n<tbody>\n<tr>\n<td>Enzymes</td>\n<td>Reaction and site</td>\n<td>Cofactors</td>\n</tr>\n<tr>\n<td><strong>P</strong>yruvate carboxylase</td>\n<td>\n<p>Pyruvate &rarr; Oxaloacetate</p>\n<p>mitochondria</p>\n</td>\n<td>\n<p>Biotin, ATP</p>\n<p>Activated by acetyl-CoA</p>\n</td>\n</tr>\n<tr>\n<td><strong>P</strong>hosphoenolpyruvate carboxykinase</td>\n<td>Oxaloacetate&nbsp;&rarr; PhosphoenolPyruvate (cytosol)</td>\n<td>GTP</td>\n</tr>\n<tr>\n<td><strong>F</strong>ructose-1,6-bisphosphatase</td>\n<td>Fructose-1,6-bisphosphate&nbsp;&rarr; fructose-6-phosphate (cytosol)</td>\n<td>\n<p>Citrate(+ve)</p>\n<p>Fructose 2,6 bisphosphate (-ve)</p>\n</td>\n</tr>\n<tr>\n<td><strong>G</strong>lucose-6-phosphatase</td>\n<td>Glucose-6-phosphate&nbsp;&rarr; glucose Endoplasmic reticulum</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6795",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is not obtained from glycine?",
      "choices": [
        {
          "id": 1,
          "text": "Creatine"
        },
        {
          "id": 2,
          "text": "Carbon atoms of purines"
        },
        {
          "id": 3,
          "text": "Heme"
        },
        {
          "id": 4,
          "text": "Nitric oxide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Nitric oxide</strong> is not a special product obtained from glycine.</p>\n<p>Products obtained from glycine:</p>\n<ul>\n<li><strong>Creatine </strong>(from glycine, arginine, and methionine)</li>\n<li><strong>Heme</strong> (from succinyl CoA and glycine)</li>\n<li><strong>Glutathione</strong> (from glutamic acid, cysteine, and glycine)</li>\n<li><strong>C4, C5, </strong>and<strong> N7 </strong>of the <strong>purine ring </strong>structure</li>\n</ul>\n<p>Note: <strong>Nitric oxide</strong> is a special product obtained from <strong>arginine.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7257",
      "difficulty": "easy"
    },
    {
      "text": "A 28-year-old male patient with short stature, disproportionate spine, barrel chest with pectus carinatum and a short neck came to the OPD. On evaluation, a diagnosis of lysosomal storage disorder is made. The glycosaminoglycan involved in the condition is a prominent component of which among the following?",
      "choices": [
        {
          "id": 1,
          "text": "Cornea"
        },
        {
          "id": 2,
          "text": "Cartilage"
        },
        {
          "id": 3,
          "text": "Kidney basement membrane"
        },
        {
          "id": 4,
          "text": "Synovial fluid"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>mucopolysaccharidoses IV</strong> and the glycosaminoglycan involved is <strong>c</strong><strong>hondroitin sulfate, </strong>which is a prominent component of <strong>cartilage</strong>.</p>\n<p>It is composed of repeating units of <strong>N-acetyl galactosamine and glucuronic acid </strong>(GAG).</p>\n<p>In this condition, the affected individuals survive into adulthood with normal faces and intellect. Short stature with a disproportionate spine, barrel chest with pectus carinatum, and short neck and limb abnormalities may be present.</p>\n<p>Some important features of chondroitin sulfate are as follows:</p>\n<ul>\n<li>The <strong>most abundant GAG</strong> in the body and is seen in the cartilage, CNS, and bone</li>\n<li>They are located at sites of calcification in endochondral bone and are a major component of <strong>cartilage</strong>.</li>\n<li>They are found in high amounts in the extracellular matrix of the central nervous system.</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Keratan sulfate I and II</strong> are the GAGs in the <strong>cornea</strong>. It is also found in cartilage and loose connective tissue. It is the only GAG that does not contain any uronic acid. The repeating units are <strong>galactose and N-acetyl glucosamine</strong> in beta linkage.</p>\n<p>Option C: <strong>Heparan sulfate </strong>is the GAG present in the <strong>kidney basement membrane</strong>, where it plays a major role in determining the charge selectiveness of glomerular filtration. It is also found in the skin. It contains repeating units of <strong>sulfated glucosamine and glucuronic acid</strong>.</p>\n<p>Option D: <strong>Hyaluronic acid</strong> is the GAG present in <strong>synovial fluid</strong>. It is also found in skin, bone, cartilage, vitreous humor, and embryonic tissues. It contains repeating units of  <strong>N-acetyl glucosamine and glucuronic acid</strong>. It plays a role in morphogenesis and wound repair. The high concentrations of hyaluronic acid along with chondroitin sulfates in cartilage contribute to its compressibility.</p>\n<p>The images below show the structure of the cartilage matrix containing glycosaminoglycans and the structure of aggrecan, a major proteoglycan present in cartilage.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/67318a8bf95c43458e32f68aec2ced49x1102x490.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ca4ee3b83d5f4ce0ad9162fcd39be183x1280x1126.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Biologically important Glycosoaminoglycans(GAG's)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>GAG</strong></p>\n</td>\n<td>\n<p><strong>Disaccharide repeat units</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Keratan sulfate</p>\n</td>\n<td>\n<p>N Acetyl Glucosamine + Galactose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyaluronic acid</p>\n</td>\n<td>\n<p>N Acetyl Glucosamine + Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chondroitin sulfate</p>\n</td>\n<td>\n<p>N Acetyl Galactosamine + Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dermatan Sulfate</p>\n</td>\n<td>\n<p>N Acetyl Galactosamine + Iduronic/ Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heparan sulfate</p>\n</td>\n<td>\n<p>N Acetyl(Fewer N-sulphated than Heparin)Glucosamine&nbsp;+ Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heparin</p>\n</td>\n<td>\n<p>N Sulphated Glucosamine + Iduronic acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0725",
      "difficulty": "medium"
    },
    {
      "text": "Which is the enzyme involved in the detoxification of ammonia in the brain?",
      "choices": [
        {
          "id": 1,
          "text": "Glutamate dehydrogenase"
        },
        {
          "id": 2,
          "text": "Glutamine synthetase"
        },
        {
          "id": 3,
          "text": "Glutamate aminotransferase"
        },
        {
          "id": 4,
          "text": "Glutaminase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Glutamine synthetase</strong> is involved in the<strong> detoxification </strong>of<strong> ammonia </strong>in the <strong>brain</strong>.<strong>&nbsp;</strong>It&nbsp;combines ammonia with glutamate to form glutamine. It <strong>requires</strong> the hydrolysis of <strong>ATP</strong>.</p>\n<p>Glutamine synthetase provides<strong> glutamine</strong> which serves as a carrier of nitrogen, carbon, and energy between organs. It also plays a major role in ammonia detoxification and in <strong>acid-base homeostasis</strong>.</p>\n<p>The <strong>deficiency</strong> of glutamine synthetase in neonates results in <strong>severe brain damage</strong>, multiorgan failure, and death.</p>\n<p>Other options:</p>\n<p>Option A:&nbsp;<strong>Glutamate dehydrogenase</strong>&nbsp;is found in the liver mitochondria and deaminates glutamate to alpha-ketoglutarate and ammonia.</p>\n<p>Option C:&nbsp;<strong>Glutamate aminotransferase</strong> converts &alpha;-amino nitrogen to ammonia along with glutamate dehydrogenase. This is termed <strong>transdeamination</strong>.</p>\n<p>Option D: <strong>Glutaminase</strong> is present in the liver and converts glutamine back to glutamate and ammonia, which is then detoxified to urea.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0710",
      "difficulty": "hard"
    },
    {
      "text": "Which among the following statements is incorrect regarding the ubiquitin-proteasome pathway?",
      "choices": [
        {
          "id": 1,
          "text": "Proteasome degrades ubiquitin tagged proteins"
        },
        {
          "id": 2,
          "text": "Ubiquitin binds to the protein by non–α-peptide bonds"
        },
        {
          "id": 3,
          "text": "Defect in this pathway leads to Angelman syndrome"
        },
        {
          "id": 4,
          "text": "Ubiquitin mainly targets extracellular proteins"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Ubiquitin mainly targets extracellular proteins is an incorrect statement. It mainly targets <strong>intracellular</strong> proteins for degradations.</p>\n<p>The ubiquitin-proteasome pathway is the pathway to degrade <strong>regulatory proteins</strong> with short half-lives, and abnormal or <strong>misfolded proteins</strong><span class=\"Apple-converted-space\"> present in the cytoplasm. This pathway <strong>requires ATP</strong>. Ubiquitin is a polypeptide present in all eukaryotic cells. It mainly targets the <strong>intracellular proteins.</strong> On identifying the target protein, it binds to it with the </span><strong>non–α-peptide bonds. </strong>The target protein may be bound by a single ubiquitin or multiple ubiquitin molecules. The tagged proteins are then degraded by <strong>proteasome.</strong></p>\n<p>Genetic disorders that result from the defect in the ubiquitin proteasome pathway include <strong>Angelman syndrome</strong>, autosomal recessive juvenile <strong>Parkinson disease</strong>, von Hippel-Lindau syndrome, and congenital polycythemia.<span class=\"Apple-converted-space\"> </span></p><p class=\"p2\">For the discovery of ubiquitin-mediated protein degradation, Aaron Ciechanover and Avram Hershko of Israel and Irwin Rose of the United States were awarded the 2004 Nobel Prize in Chemistry.<span class=\"Apple-converted-space\"> </span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0335",
      "difficulty": "medium"
    },
    {
      "text": "A 9-year-old boy is brought to the pediatrician by his mother with complaints of self-biting his lips and nails. On examination, the child has delayed developmental milestones, spasticity, and dystonia. Nail findings are as shown in the image below. Laboratory investigations reveal elevated uric acid levels. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Autism"
        },
        {
          "id": 2,
          "text": "Lesch-Nyhan disease"
        },
        {
          "id": 3,
          "text": "Severe combined immunodeficiency"
        },
        {
          "id": 4,
          "text": "Tourette’s disorder"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above clinical scenario with the image showing <strong>self-mutilation</strong> and laboratory values showing <strong>hyperuricemia</strong> is most likely suggestive of <strong>Lesch-Nyhan disease</strong>.</p>\n<p>Lesch-Nyhan syndrome is an <strong>X-linked recessive</strong> disorder due to a complete deficiency of the hypoxanthine-guanine phosphoribosyltransferase (<strong>HGPRT</strong>). This deficiency results in an <strong>inability to salvage</strong> hypoxanthine or guanine leading to&nbsp;<strong>increased levels of phospho-ribosyl pyrophosphate (PRPP). </strong>Increased&nbsp;PRPP leads to increased purine synthesis, which is later degraded to <strong>uric acid</strong>. Increased hypoxanthine is also converted to uric acid.</p>\n<p>The patients have <strong>intellectual disability</strong>, behaviors of <strong>self-injury</strong> like lip and finger biting, <strong>developmental delay</strong>, <strong>muscle dystonia,</strong> and extrapyramidal symptoms.&nbsp;</p>\n<p>Diagnosis is made by the <strong>elevated</strong> levels of <strong>uric acid</strong> and by HGPRT enzyme assay.</p>\n<p>The image given below shows the metabolism of hypoxanthine and guanine by HGPRT.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d295845ea4924b19ab07ca33a23f65bex1280x1203.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: <strong>Autism</strong> mainly presents with <strong>problems</strong> in <strong>social communication</strong> and social interaction. They have poor verbal and non-verbal communication, <strong>absence of eye contact</strong>, <strong>repetitive behaviors</strong>&nbsp;like&nbsp;lining up toys or flipping objects, echolalia, etc. Intellectual impairment may or may not be present.</p>\n<p>Option C: Patients with severe combined immunodeficiency (<strong>SCID)</strong> present with <strong>infections.&nbsp;</strong>Diarrhea, pneumonia, otitis media, sepsis, and cutaneous infections are common presentations. It is caused by various genetic mutations that lead to the absence of T and B-cell function. They have a <strong>low lymphocyte count.</strong></p>\n<p>Option D: <strong>Tourette&rsquo;s disorder&nbsp;</strong>is characterized by sudden repetitive, non-rhythmic motor movements or sounds. They present with loud grunting or barking noises or shouting obscene words. Motor tics include&nbsp;tongue protrusion, sniffing, hopping, squatting, blinking, or nodding.</p><hr><h3>Related Pearl: Purine salvage deficiencies: Lesch-Nyhan syndrome and Adenosine deaminase deficiency(SCID)</h3><p><strong>Severe Combined Immunodeficiency(SCID):</strong></p>\n<p><strong>Adenosine deaminase</strong>&nbsp;enzyme deficiency is one of the major cause of SCID. It is also called as&nbsp;<strong>Glanzmann&ndash;Riniker syndrome.</strong></p>\n<p>SCID patients are usually affected by severe bacterial, viral, or fungal infections early in life and often present with interstitial lung disease, chronic diarrhea, and failure to thrive.</p>\n<p><strong>Lesch-Nyhan syndrome:</strong></p>\n<p>It is due to deficiency of the enzyme<strong> Hypoxanthine-guanine phosphoribosyltransferase(HGPRT). </strong>It is an X-linked recessive disease.</p>\n<p>Clinical features:</p>\n<ul>\n<li><span class=\"fontstyle0\">Intellectual disability</span></li>\n<li><span class=\"fontstyle0\">Self-mutilation</span></li>\n<li><span class=\"fontstyle0\">Aggression</span></li>\n<li>Hyperuricemia&nbsp;</li>\n<li><span class=\"fontstyle0\">Gout<br /></span></li>\n</ul>\n<p><span class=\"fontstyle0\">Treatment:</span></p>\n<ul>\n<li><span class=\"fontstyle0\">Allopurinol</span></li>\n<li><span class=\"fontstyle0\">Febuxostat</span></li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/134fbd5ce06b457a83ccae31f8bad2b5.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0334",
      "difficulty": "easy"
    },
    {
      "text": "What is the defective DNA repair mechanism in a patient with SCID? <div class='question-desc-html'><p>(SCID - severe combined immunodeficiency)</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Mismatch repair"
        },
        {
          "id": 2,
          "text": "Nucleotide excision repair"
        },
        {
          "id": 3,
          "text": "Non-homologous end joining repair"
        },
        {
          "id": 4,
          "text": "Homologous recombination"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>SCID is associated with a <strong>defective non-homologous end-joining </strong>(NHEJ). </p>\n<p>NHEJ is a predominant pathway for <strong>DNA double-stranded break repair.</strong> NHEJ also functions in class switch recombination, enhancing T and B cell diversity. Thus, NHEJ deficiency leads to combined immunodeficiency due to a failure to carry out recombination efficiently. </p>\n<p><strong>Severe combined immunodeficiency (SCID) </strong>is characterised by defects in <strong>both humoral</strong> and <strong>cell-mediated</strong> immune responses. Genes involved are JAK3, RAG1, and IL-7R. Persons with SCID are extremely susceptible to <strong>recurrent, severe infections</strong> by a wide range of pathogens, including <em>Candida albicans, Pneumocystis jirovecii, Pseudomonas</em> species, cytomegalovirus, varicella, and a host of other bacteria. </p>\n<p><strong>X-linked SCID</strong> is the <strong>most common form,</strong> accounting for 50% to 60% of cases, is X-linked, and hence, SCID is more<strong> common</strong> in <strong>boys</strong>. The genetic defect is a <strong>mutation</strong> in the<strong> common γ-chain </strong>(γc) <strong>subunit </strong>of <strong>cytokine receptors</strong>. In these patients, the thymus contains lobules of<strong> undifferentiated epithelial cells, </strong>resembling fetal thymus.</p>\n<p><strong>Autosomal recessive SCID</strong> is commonly caused by a<strong> deficiency</strong> of <strong>adenosine deaminase </strong>(ADA) enzyme. In these patients, the thymus contains remnants of <strong>Hassall’s corpuscles.</strong></p><hr><h3>Related Pearl: Human Diseases of DNA Damage Repair</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>DNA damage repair type</strong></p>\n</td>\n<td>\n<p><strong>Diseases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Nonhomologous End Joining Repair (NHEJ)</p>\n</td>\n<td>\n<p>Severe combined immunodeficiency disease (SCID)</p>\n<p>Radiation sensitive severe combined immunodeficiency disease(RS-SCID)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Homologous Repair (HR)</p>\n</td>\n<td>\n<p>AT-like disorder (ATLD)</p>\n<p>Nijmegen breakage syndrome (NBS)</p>\n<p>Bloom syndrome (BS)</p>\n<p>Werner syndrome (WS)</p>\n<p>Rothmund-Thomson syndrome (RTS)</p>\n<p>Breast cancer suspectibility 1 and 2 (BRCA1, BRCA2)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Nucleotide Excision Repair (NER)</p>\n</td>\n<td>\n<p>Xeroderma pigmentosum (XP)</p>\n<p>Cockayne syndrome (CS)</p>\n<p>Trichothiodystrophy (TTD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Base Excision Repair (BER)</p>\n</td>\n<td>\n<p>MUTYH-associated polyposis (MAP)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Mismatch Repair (MMR)</p>\n</td>\n<td>\n<p>Hereditary nonpolyposis colorectal cancer (HNPCC)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0475",
      "difficulty": "easy"
    },
    {
      "text": "FIGLU (Formiminoglutamic acid) excretion test is used in the assessment of the deficiency of which of the following vitamins?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin B1"
        },
        {
          "id": 2,
          "text": "Vitamin B6"
        },
        {
          "id": 3,
          "text": "Vitamin B9"
        },
        {
          "id": 4,
          "text": "Vitamin B12"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>FIGLU excretion test is used in the assessment of <strong>deficiency</strong> of&nbsp;<strong>Vitamin B9</strong> (Folic acid).</p>\n<p>FIGLU is converted to L-glutamate by the enzyme glutamate formimino transferase. This enzyme uses <strong>folate </strong>(vitamin B9). In Vitamin B9 deficiency, FIGLU accumulates in the body and is excreted in the urine.</p>\n<p>Folic acid is a water-soluble vitamin, and its <strong>active form</strong> is <strong>tetrahydrofolate&nbsp;</strong>(THFA). It acts as a carrier of <strong>one-carbon groups.</strong> These one-carbon groups are attached either to the 5th, 10th, or both 5th and 10th nitrogen atoms of THFA.</p>\n<div class=\"page\" title=\"Page 416\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The methyl group in N5-methyl THFA is used for the synthesis of active <strong>methionine</strong>. This takes part in <strong>transmethylation</strong> reactions required for the synthesis of choline, epinephrine, creatine, etc.</p>\n<p>Folate deficiency results in</p>\n<ul>\n<li>Reduced synthesis of DNA</li>\n<li>Macrocytic anemia</li>\n<li>Hyperhomocysteinemia</li>\n<li>Neural tube defects in the fetus like spina bifida</li>\n</ul>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d74222a8ec5649b1a6c24d1170fde087x1280x1530.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Biochemical Assay for Vitamin Deficiency State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Assay and test</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B1 (Thiamine)</p>\n</td>\n<td>\n<p>RBC Trans-ketolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B2 (Riboflavin)</p>\n</td>\n<td>\n<p>RBC glutathione reductase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 (Pyridoxine)</p>\n</td>\n<td>\n<p>RBC transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B9 (Folic acid)</p>\n</td>\n<td>\n<p>FIGLU excretion/Histidine load test</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B12 (Cobalamine)</p>\n</td>\n<td>\n<p>Serum methyl malonate level</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Active Forms and Functions of Water-Soluble Vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\">\n<p>Vitamin</p>\n</td>\n<td colspan=\"2\">\n<p>Coenzyme</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Name</p>\n</td>\n<td>\n<p>Function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B1(Thiamin)</p>\n</td>\n<td>\n<p>Thiamine pyrophosphate (TPP)</p>\n</td>\n<td>\n<p>Decarboxylation</p>\n<p>Transketolase reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B2(Riboflavin)</p>\n</td>\n<td>\n<p>Flavin-adenine-dinucelotide (FAD)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B3(Nicotinic acid, niacin)</p>\n</td>\n<td>\n<p>Nicotinamide-adenine dinucleotide(NAD<sup>+</sup>)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B5(Pantothenic acid)</p>\n</td>\n<td>\n<p>Coenzyme A</p>\n</td>\n<td>\n<p>Transfer of an acyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B6(Pyridoxine)</p>\n</td>\n<td>\n<p>Pyridoxal Phosphate(PLP)</p>\n</td>\n<td>\n<p>Transamination</p>\n<p>Decarboxylation</p>\n<p>Co-factor of glycogen phosphorylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B7(Biotin)</p>\n</td>\n<td>\n<p>Biotin</p>\n</td>\n<td>\n<p>Carboxylation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B9(Folic acid)</p>\n</td>\n<td>\n<p>Tetrahydrofolic acid (THFA)</p>\n</td>\n<td>\n<p>Donor of methyl/formyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B12(Cobalamin)</p>\n</td>\n<td>\n<p>Methylcobalamin and Adenosylcobalamin</p>\n</td>\n<td>\n<p>Co-factor of methionine synthase and methylmalonyl CoA mutase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C (Ascorbic acid)</p>\n</td>\n<td>Ascorbic acid and dehydroascorbic acid</td>\n<td>\n<p>Oxidation-reduction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9980",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following amino acid is used for the conversion of norepinephrine to epinephrine?",
      "choices": [
        {
          "id": 1,
          "text": "Glycine"
        },
        {
          "id": 2,
          "text": "Alanine"
        },
        {
          "id": 3,
          "text": "Methionine"
        },
        {
          "id": 4,
          "text": "Serine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Methionine</strong> in the form of <strong>S-adenosyl methionine</strong> is used during the conversion of <strong>norepinephrine</strong> to <strong>epinephrine.</strong></p>\n<p>Function of S-Adenosyl methionine:</p>\n<p><strong>1.</strong> <strong>Transmethylation reactions:</strong></p>\n<ul>\n<li>Norepinephrine to Epinephrine</li>\n<li>Ethanolamine to Choline</li>\n<li>Acetyl serotonin to Melatonin</li>\n<li>Guanidinoacetate to Creatine</li>\n</ul>\n<p><strong>2.  DNA methylation</strong></p>\n<p><strong>3.  Polyamine synthesis:</strong></p>\n<ul>\n<li>Cadaverine</li>\n<li>Putrescine</li>\n<li>Spermidine</li>\n<li>Spermine</li>\n</ul><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6829",
      "difficulty": "easy"
    },
    {
      "text": "Calnexin is mainly involved in:",
      "choices": [
        {
          "id": 1,
          "text": "Folding of proteins"
        },
        {
          "id": 2,
          "text": "Calcium metabolism"
        },
        {
          "id": 3,
          "text": "Ubiquitination of proteins"
        },
        {
          "id": 4,
          "text": "Signaling release of calcium from endoplasmic reticulum"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Calnexin</strong> is a <strong>lectin chaperone</strong> that is involved in the <strong>folding of glycoproteins</strong> and it is located in the membrane of the <strong>endoplasmic reticulum.</strong></p>\n<p>It binds to various proteins like the <strong>major histocompatibility complex </strong>(MHC) antigens and&nbsp;<strong>plasma proteins. </strong>It makes the proteins stay within the endoplasmic reticulum until they are properly folded.</p>\n<p><strong>Calreticulin </strong>is another chaperone and calcium-binding protein, similar to calnexin but it is <strong>not membrane-bound.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9498",
      "difficulty": "hard"
    },
    {
      "text": "An infant presents with poor feeding. He has tachycardia and tachypnoea along with enlarged tongue, hypotonia, skeletal muscle weakness, and hepatomegaly. Laboratory investigations reveal elevated serum CK, AST,  ALT, LDH, and urine glucose tetrasaccharide. Chest X-ray is done later as shown below.  What is the most likely diagnosis?<div class='question-desc-html'><p>CK-creatine kinase ; AST-aspartate aminotransferase ; ALT-alanine aminotransferase ; LDH-lactate dehydrogenase</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Von Gierke disease"
        },
        {
          "id": 2,
          "text": "Pompe disease"
        },
        {
          "id": 3,
          "text": "Mc Ardle disease"
        },
        {
          "id": 4,
          "text": "Tarui disease"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>From the above-given clinical scenario and the radiograph showing <strong>cardiomegaly</strong> (tachycardia and tachypnoea), <strong>Pompe's disease</strong> is the most likely diagnosis. The clinical symptoms of Pompe disease are <strong>hypotonia</strong> (floppy infant), skeletal muscle weakness, <strong>hepatomegaly</strong>, hypertrophic <strong>cardiomyopathy</strong> and <strong>macroglossia.</strong> </p>\n<p><strong>Pompe's disease </strong>(Type 2 glycogen storage disease) is an autosomal recessive disorder that occurs due to <strong>α-1,4-glucosidase (acid maltase)</strong> deficiencyleading to lysosomal glycogen accumulation in cardiac, skeletal, and smooth muscle cells. It can appear within <strong>weeks or months</strong> after birth (infantile Pompe disease) or may appear late in juvenile, childhood, or adulthood disease (late-onset Pompe disease).</p>\n<p>Laboratory findings will show elevated levels of serum creatine kinase (CK), aspartate transaminase (AST), alanine transaminase (ALT), and lactate dehydrogenase (LDH). <strong>Urine glucose tetrasaccharide,</strong> a glycogen breakdown metabolite, is a reliable biomarker for disease severity and treatment response.</p>\n<p>Muscle biopsy shows the presence of vacuoles that stain positively for <strong>glycogen. </strong>It is diagnosed by detecting the decreased activity of the enzyme, <strong>α-1,4-glucosidase</strong> in the dried blood spots, leukocytes, blood mononuclear cells, muscle, or cultured skin fibroblasts.</p>\n<p>Other options</p>\n<div class=\"page\" title=\"Page 3442\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option A- <strong>Von Gierke disease </strong>occurs due to a deficiency of <strong>glucose-6-phosphatase.</strong> Patients present commonly in 3-4 months of age with <strong>hypoglycemia, lactic acidosis,</strong> hepatomegaly, growth retardation, hyperuricemia, and hyperlipidemia.</p>\n<p>Option C- <strong>McArdle disease</strong> occurs due to <strong>myophosphorylase</strong> deficiency leading to reduced ATP generation. The typical manifestations are myoglobinuria (secondary to rhabdomyolysis), muscle pain and cramps after heavy exercise. This pain may reduce after a brief period of rest and the patient may be able to perform an exercise. This is called the <strong>second wind phenomenon</strong>. Cardiomyopathy is not seen in this condition.</p>\n<p>Option D- <strong>Tarui disease</strong> (Type VII glycogen storage disorder)<strong> </strong>occurs due to the deficiency of muscle phosphofructokinase. The main clinical features are exercise intolerance, cramps, <strong>hemolytic anemia,</strong> and myoglobinuria. There is no hypertrophic cardiomyopathy.</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Glycogen Storage Diseases</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/782e85c36f0648698a222dca988adfabx1280x1863.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficiency</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type 0</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n<td>\n<p>Hypoglycemia</p>\n<p>Early death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ia</p>\n<p><strong>Von Gierke's disease</strong></p>\n</td>\n<td>\n<p>Glucose-6- phosphatase</p>\n</td>\n<td>\n<p>Hepatomegaly and renomegaly&nbsp;due to glycogen accumulation</p>\n<p>Severe fasting hypoglycemia</p>\n<p>Growth failure</p>\n<p>Lactic acidosis</p>\n<p>Hyperuricemia</p>\n<p>Hyperlipidemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ib</p>\n</td>\n<td>\n<p>Endoplasmic reticulum glucose-6- phosphate transporter</p>\n</td>\n<td>\n<p>Same as Von Gierke's disease</p>\n<p>Recurrent infections due to impaired neutrophil function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type II</p>\n<p><strong>Pompe's disease</strong></p>\n</td>\n<td>\n<p>Lysosomal &alpha;1,4:1,6 glucosidase</p>\n<p>(Acid maltase)</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Death by age ~ 2 years (infantile variant)</p>\n<p>Cardiomegaly and heart failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type III</p>\n<p><strong>Cori's/Forbes disease</strong></p>\n<p>(Limit dextrinosis)</p>\n</td>\n<td>\n<p>Glycogen debranching enzyme</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Fasting hypoglycemia</p>\n<p>Hepatomegaly due to accumulation of branched-chain polysaccharide (limit dextrins)</p>\n<p>Growth retardation</p>\n<p>Normal lactate and uric acid levels</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type IV</p>\n<p><strong>Andersen disease</strong></p>\n</td>\n<td>\n<p>Glycogen branching enzyme</p>\n</td>\n<td>\n<p>Failure to thrive</p>\n<p>Hepatomegaly due to accumulation of polysaccharides with few branch points</p>\n<p>Death at age ~ 5 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type V</p>\n<p><strong>McArdle disease</strong></p>\n</td>\n<td>\n<p>Muscle glycogen phosphorylase</p>\n</td>\n<td>\n<p>Exercise-induced cramps</p>\n<p>Renal failure due to rhabdomyolysis and myoglobinuria</p>\n<p>Second wind phenomenon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VI</p>\n<p><strong>Her's disease</strong></p>\n</td>\n<td>\n<p>Liver glycogen phosphorylase</p>\n</td>\n<td>\n<p>Generally benign</p>\n<p>Mild hypoglycemia</p>\n<p>Hepatomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VII</p>\n<p><strong>Tarui's disease</strong></p>\n</td>\n<td>\n<p>Muscle phosphofructokinase</p>\n</td>\n<td>\n<p>Exercise-induced muscle cramps and weakness</p>\n<p>Growth retardation</p>\n<p>Hemolytic anemia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Enzyme Replacement Therapy for Lysosomal Storage Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Lysosomal Storage Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficient</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Replacement Therapy</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hurler Syndrome (MPS I)</p>\n</td>\n<td>\n<p>&alpha;-L -iduronidase</p>\n</td>\n<td>\n<p>Laronidase (Aldurazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hunter Syndrome (MPS II)</p>\n</td>\n<td>\n<p>Iduronate sulfate sulfatase</p>\n</td>\n<td>\n<p>Idursulfase (Elaprase)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Morquio A Syndrome (MPS IVA)</p>\n</td>\n<td>\n<p>N-Acetylgalactosamine-6-sulfate sulfatase</p>\n</td>\n<td>\n<p>Elosulfase (Vimizim)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maroteaux&ndash;Lamy Syndrome (MPS VI)</p>\n</td>\n<td>\n<p>N -Acetylgalactosamine-&alpha;-4-sulfate sulfatase (arylsulfatase B)</p>\n</td>\n<td>\n<p>Galsulfase (Naglazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sly syndrome (MPS VII)</p>\n</td>\n<td>&beta;-Glucuronidase</td>\n<td>\n<p>rhGUS (recombinant human&nbsp;&beta;-Glucuronidase is under Phase III trial)</p>\n</td>\n</tr>\n<tr>\n<td>Wolman disease</td>\n<td>Lysosomal acid lipase</td>\n<td>\n<p><em> Sebelipase alfa</em>(Kanuma, Alexion)</p>\n</td>\n</tr>\n<tr>\n<td>Metachromatic leukodystrophy</td>\n<td>Arylsulfatase A</td>\n<td>\n<p>rhARSA (recombinant human arylsulfatase A is under Phase I/II trial)</p>\n</td>\n</tr>\n<tr>\n<td>Fabry disease&nbsp;</td>\n<td>&alpha;-galactosidase A</td>\n<td>\n<p><em>agalsidase beta</em> (Fabrazyme, Genzyme)</p>\n<p><em>agalsidase alfa</em> (Replagal, Shire HGT)</p>\n</td>\n</tr>\n<tr>\n<td>Gaucher disease</td>\n<td>&beta;-glucosidase</td>\n<td>\n<p><em>imiglucerase </em>[Cerezyme, Genzyme]</p>\n<p><em>velaglucerase alfa </em>[VPRIV, Shire HGT]</p>\n<p><em>taliglucerase alfa </em>(Uplyso, Protalix<br />Biotherapeutics)</p>\n<p><em>eliglusta</em>t (Cerdelga, Sanofi-Genzyme)</p>\n</td>\n</tr>\n<tr>\n<td>Pompe disease</td>\n<td>acid &alpha;-1,4-glucosidase (acid maltase)&nbsp;</td>\n<td>\n<p><em>alglucosidase alfa </em>(Myozyme)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f7c8920e5d384fb3b49da7aecac758ce.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0326",
      "difficulty": "easy"
    },
    {
      "text": "The echocardiography report of a 35-year-old woman hailing from China indicates dilated cardiomyopathy. Which of the following conditions can explain her diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Selenium toxicity"
        },
        {
          "id": 2,
          "text": "Selenium deficiency"
        },
        {
          "id": 3,
          "text": "Zinc toxicity"
        },
        {
          "id": 4,
          "text": "Zinc deficiency"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The patient is probably suffering from <strong>Keshan's disease</strong>, which is due to <strong>selenium deficiency</strong>.</p>\n<p>Keshan disease is <strong>endemic cardiomyopathy</strong> found in children and young women residing in regions of <strong>China</strong> where <strong>dietary intake</strong> of <strong>selenium</strong> is <strong>low</strong>. Mainly <strong>dilated cardiomyopathy</strong> is characteristic, and may also result in cardiomegaly, congestive cardiac failure and fulminant cardiogenic shock.</p>\n<p>Selenium is an important trace element that is a <strong>part </strong>of the<strong> 21st amino acid selenocysteine</strong>. There are many selenium-containing enzymes such as:</p>\n<ul>\n<li>Glutathione peroxidase</li>\n<li>De-iodinase</li>\n<li>Thioredoxin reductase</li>\n</ul>\n<p>Selenium is also an <strong>intracellular antioxidant</strong> that complements the role of vitamin E. Dietary sources of selenium include seafood, muscle meat, and some cereals.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4027",
      "difficulty": "easy"
    },
    {
      "text": "A dietician advising a patient regarding diet plans considers the specific dynamic action (SDA) values for proteins, lipids, and carbohydrates. Identify the correct sequence of SDA values in these substrates.",
      "choices": [
        {
          "id": 1,
          "text": "Lipids  > Carbohydrates > Proteins"
        },
        {
          "id": 2,
          "text": "Carbohydrates > Proteins > Lipids"
        },
        {
          "id": 3,
          "text": "Proteins > Lipids >  Carbohydrates"
        },
        {
          "id": 4,
          "text": "Lipids > Proteins > Carbohydrates"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Among the given options, option C represents the correct sequence of specific dynamic values (<strong>SDA)</strong> of<strong> proteins &gt; lipids &gt; carbohydrates.</strong></p>\n<p><strong>Specific dynamic allowance </strong>(previously called the thermic effect of food): This refers to the increased heat production or increased metabolic rate following the intake of food (diet-induced thermogenesis).</p>\n<p class=\"p1\">The values of SDA are</p>\n<ul>\n<li class=\"p1\"><strong>30%</strong> for<strong> proteins:</strong> This means that out of every 100 grams of proteins consumed, the energy available for doing useful work is 30% less than the calculated value.</li>\n<li class=\"p1\"><strong>15%</strong> for<strong> lipids</strong>, and </li>\n<li class=\"p1\"><strong>5% </strong>for <strong>carbohydrates.</strong></li>\n</ul>\n<p class=\"p1\"><strong>Importance</strong>: It is a common experience that during hot weather following the consumption of a protein-rich meal, one feels hot and humid for a while. On the other hand, in cold weather, the same would provide a comfortable feeling.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6560",
      "difficulty": "medium"
    },
    {
      "text": "A research fellow in biochemistry is studying the lac operon concept of gene regulation. He cultures E. coli. in a glucose-deficient and lactose-containing medium. Which of the following genes expressed in this condition helps convert lactose to galactose and glucose?",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "3"
        },
        {
          "id": 3,
          "text": "4"
        },
        {
          "id": 4,
          "text": "2"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The gene marked as 2 is the <strong>lac Z gene</strong>, which codes for <strong>&beta;-galactosidase.&nbsp;</strong>This enzyme converts <strong>lactose to&nbsp;galactose and glucose.</strong></p>\n<p><strong>Lac operon concept</strong></p>\n<p>Jacob and Monod<span class=\"Apple-converted-space\">&nbsp;studied the Lac operon model, which is the&nbsp;</span>regulation of lactose metabolism by the intestinal bacterium <em>Escherichia coli</em>.<span class=\"Apple-converted-space\">&nbsp;It is switched on when the bacteria have to utilize lactose for utilization. Otherwise, it is switched off. It contains the following genes:</span></p>\n<ul>\n<li><span class=\"Apple-converted-space\"><strong>lac I</strong>- it codes for the repressor protein</span></li>\n<li><span class=\"Apple-converted-space\">cAMP response element (<strong>CRE</strong>)- It is activated by binding the&nbsp;</span>cyclic AMP activator protein (CAP). When activated, it increases the binding of&nbsp;RNA polymerase<span class=\"Apple-converted-space\">&nbsp;and increases gene expression.</span></li>\n<li><span class=\"Apple-converted-space\"><strong>Promoter site</strong>- It is the site where RNA polymerase binds the gene for transcription.&nbsp;</span></li>\n<li><span class=\"Apple-converted-space\"><strong>Operator site</strong>- It is the site where repressor protein binds.</span></li>\n<li><span class=\"Apple-converted-space\"><strong>lac Z gene</strong>- It codes for&nbsp;</span><strong>&beta;-Galactosidase</strong> that hydrolyzes lactose to galactose and glucose.<span class=\"Apple-converted-space\">&nbsp;</span></li>\n<li><span class=\"Apple-converted-space\"><strong>lac Y</strong>- It encodes for <strong>lactose permease</strong>, which increases the permeability of lactose into the cells.</span></li>\n<li><span class=\"Apple-converted-space\"><strong>lac A</strong>- It encodes for&nbsp;</span><strong>thiogalactoside transacetylase</strong>.<strong><span class=\"Apple-converted-space\">&nbsp;</span></strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/16246ae4498f4884b204646c1cc079d4x1280x746.JPEG\" alt=\"Explanation Image\"><p><span class=\"Apple-converted-space\">For the working of Lac operon, the <strong>operator site should be free</strong> and the&nbsp;<strong>CRE</strong> site should be <strong>activated.</strong></span></p>\n<p>1. When <strong>glucose</strong> is <strong>present</strong> and <strong>lactose</strong> is <strong>absent</strong>- The bacteria utilize glucose. The lac I gene produces <strong>repressor protein</strong>,<strong>&nbsp;</strong>which binds to the <strong>operator site</strong>.&nbsp;Repressor-operator binding prevents the binding of RNA polymerase and, consequently, prevents transcription of the lacZ, lacY, and lacA structural genes into a polycistronic mRNA.<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p><span class=\"Apple-converted-space\">In addition to this, excess glucose inhibits&nbsp;</span>adenylyl cyclase. Therefore, the production of cAMP is reduced. Less cAMP means less&nbsp;cyclic AMP activator protein (CAP) binding to CRE. CRE is not activated, and lac operon is <strong>switched off.</strong></p>\n<p><span class=\"Apple-converted-space\">2. When <strong>glucose</strong> is <strong>absent</strong> and <strong>lactose</strong> is<strong> present</strong>- Bacteria utilize lactose. The lactose inactivates the repressor protein. This prevents the binding of repressor protein to the operator site. The operator site is now free and RNA polymerase can<strong> start</strong> with the transcription. The low</span><span class=\"Apple-converted-space\">&nbsp;glucose level causes an increase in the&nbsp;adenylyl cyclase activity, and increases the cAMP levels. This increases the binding of CAP to CRE, which in turn activates the transcription of the&nbsp;lacZ, lacY, and lacA structural genes into polycistronic mRNA.&nbsp;</span></p>\n<p><span class=\"Apple-converted-space\">3. When both&nbsp;<strong>glucose</strong> and <strong>lactose</strong>&nbsp;are <strong>present-</strong> The bacteria utilize glucose. The unused lactose binds to the repressor protein and renders it inactive. The operator site is free. However, the increased glucose level inhibits adenylyl cyclase and decreases the cAMP levels. Therefore, even though the operator site is free, CRE is not activated, which leads to the&nbsp;<strong>switching off</strong>&nbsp;of the lac operon.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/722459effdb747beb9146605b547ac05x512x384.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5fd6e348858c4028a52c16ec95ec7736x637x326.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Difference between Lac & tryptophan operon</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lac Operon</strong></p>\n</td>\n<td>\n<p><strong>Tryptophan Operon</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inducible gene complex</p>\n</td>\n<td>\n<p>Repressible gene complex</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Catabolic system</p>\n</td>\n<td>\n<p>Anabolic system</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Contain 3 structural genes</p>\n</td>\n<td>\n<p>Contains 5 structural gene</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Produce 3 inducible enzymes</p>\n</td>\n<td>\n<p>Produce 5 Repressible enzymes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Repressor protein is active</p>\n</td>\n<td>\n<p>Repressor protein is inactive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>High lactose turn transcription on , in low glucose level</p>\n</td>\n<td>\n<p>High tryptophan transcription off</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lactose act as inducer</p>\n</td>\n<td>\n<p>Tryptophan act as co-repressor</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Has only 1 type of gene regulation-Negative&nbsp; control</p>\n</td>\n<td>\n<p>Has only 1 type of gene regulation-Negative control</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Usually OFF, Get activated under certain conditions</p>\n</td>\n<td>\n<p>Usually ON, inactive at high level of tryptophan.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>cAMP is necessary for CAP to switch transcription on</p>\n</td>\n<td>\n<p>cAMP is not&nbsp; necessary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0dc6b32e2315408faa502cd1bdc8bf47.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0373",
      "difficulty": "medium"
    },
    {
      "text": "All of the following types of interactions cooperate in stabilizing the tertiary structures of globular proteins except _____.",
      "choices": [
        {
          "id": 1,
          "text": "Disulphide bonds"
        },
        {
          "id": 2,
          "text": "Hydrogen bonds"
        },
        {
          "id": 3,
          "text": "Ionic interactions"
        },
        {
          "id": 4,
          "text": "Peptide bonds"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Peptide bonds</strong> are not involved in stabilizing tertiary structure of proteins. It forms the <strong>primary structure</strong> of proteins.</p>\n<p>Interactions stabilizing <strong>tertiary structure</strong> of proteins are as follows:</p>\n<ul>\n<li>Hydrophobic interactions</li>\n<li>Hydrogen bonds</li>\n<li>Ionic interactions</li>\n<li>Disulphide bonds</li>\n</ul>\n<p><strong>Note</strong>:</p>\n<p>Hydrogen bonds and Van der Waal interactions are involved in the formation of α helix (secondary structure).</p><hr><h3>Related Pearl: Structure of proteins</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fd214b3bb95411197397c70b51294d9x1280x2196.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8361",
      "difficulty": "medium"
    },
    {
      "text": "CO2 is released in which of the following steps of the tricarboxylic acid (TCA) cycle?",
      "choices": [
        {
          "id": 1,
          "text": "Steps A and B"
        },
        {
          "id": 2,
          "text": "Steps B and C"
        },
        {
          "id": 3,
          "text": "Steps C and D"
        },
        {
          "id": 4,
          "text": "Steps D and E"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>CO2 is released in<strong> steps B and C</strong>.<strong> </strong>Step B is the conversion of isocitrate to ketoglutarate which is catalyzed by isocitrate dehydrogenase. Step C is the conversion of ketoglutarate to succinate which is catalyzed by alpha-ketoglutarate dehydrogenase. In these steps, there are <strong>releases of CO<sub>2</sub></strong> and conversion of <strong>NAD+ to NADH</strong>.</p>\n<p>The <strong>tricarboxylic acid cycle (TCA, Kreb's cycle, or citric acid cycle)</strong> refers to a sequence of reactions that take place in the <strong>mitochondria. </strong>It oxidizes acetyl-CoA to CO2 and reduces coenzymes that are reoxidized through the electron transport chain, with the formation of ATP. It is an <strong>aerobic</strong> pathway.</p>\n<p>The TCA cycle is the final common pathway for the oxidation of carbohydrates, lipids, and proteins. Most amino acids get metabolized either to acetyl CoA or to an intermediate of the cycle. It plays an important role in gluconeogenesis, lipogenesis, and the interconversion of amino acids. Since it functions in both <strong>oxidative</strong> as well as <strong>synthetic processes</strong>, it is an <strong>amphibolic</strong> pathway.</p>\n<div class=\"page\" title=\"Page 164\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>3 molecules of NADH</strong> and <strong>1 molecule of FADH2</strong> are produced for each molecule of acetyl-CoA that is catabolized during one turn of the TCA cycle. Each NADH gives approximately 2.5 ATP and FADH2 gives 1.5 ATP when they are reoxidized. In addition, 1 ATP (or GTP) is formed at the substrate level when succinyl CoA is converted to succinate. Thus, <strong>10 ATP are generated for one turn of the TCA cycle</strong> (3x2.5 ATP from NADH +1.5 ATP from FADH2+1GTP).</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Steps involved in TCA cycle</h3><table>\n<tbody>\n<tr>\n<td><strong>Step 1</strong></td>\n</tr>\n<tr>\n<td>\n<p>Acetyl CoA + Oxaloacetate &rarr; Citrate</p>\n<p>&nbsp; &nbsp; &nbsp;(2C &nbsp;+ 4C &nbsp;= &nbsp; 6C)</p>\n<p>Enzyme: Citrate Synthase</p>\n<p><strong>Irreversible</strong>, Exothermic reaction</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 2</strong></td>\n</tr>\n<tr>\n<td>\n<p>Citrate &rarr; Cis &ndash;aconitate&nbsp; &rarr; Isocitrate&nbsp;</p>\n<p>( 6C &nbsp; &nbsp;&rarr; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;6C &rarr; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6C)</p>\n<p>Enzyme:&nbsp;&nbsp; <strong>Aconitase</strong></p>\n<p>Cofactor:&nbsp;&nbsp; Fe<sup>2+</sup></p>\n<p>The Reaction occurs in 2 steps: &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>1<sup>st</sup> step:&nbsp; Dehydration&nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>2<sup>nd</sup> step:&nbsp; Rehydration</p>\n<p>Inhibited by:<strong> Fluoroacetate (Non- Competitive)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 3</strong></td>\n</tr>\n<tr>\n<td>\n<p>Isocitrate &rarr;[Oxalosuccinate]&rarr;&alpha;- Keto glutarate</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; (6C) &rarr; &nbsp; &nbsp; &nbsp; &nbsp; [6C] &nbsp; &nbsp; &nbsp; &nbsp; &rarr; &nbsp; &nbsp; &nbsp; &nbsp; (<strong>5C</strong>)</p>\n<p>Enzyme:&nbsp; Isocitrate Dehydrogenase</p>\n<p>Cofactor:&nbsp;&nbsp; Mn<sup>2+ </sup>or Mg<sup>2+</sup></p>\n<p>Reaction: &nbsp;Oxidative &nbsp;Decarboxylation</p>\n<p><strong>Intermediate:&nbsp;&nbsp; Oxalosuccinate [ Unstable]</strong></p>\n<p>Release:&nbsp;&nbsp;&nbsp; 1 NADH and CO2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 4</strong></td>\n</tr>\n<tr>\n<td>\n<p>&alpha;- Keto glutarate &rarr; Succcinyl Co A&nbsp;</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp;(5C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &rarr; &nbsp; &nbsp; &nbsp; &nbsp; 4C)</p>\n<p>Enzyme: &alpha;- Ketoglutarate Dehydrogenase(Multienzyme complex)</p>\n<p>Reaction:&nbsp; Oxidative Decarboxylation</p>\n<p>Inhibited by: <strong>Arsenite&nbsp; (Non &ndash; Competitive)</strong></p>\n<p>Physiologically <strong>unidirectional</strong> step.</p>\n<p>Release: 1 NADH and CO2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 5</strong></td>\n</tr>\n<tr>\n<td>\n<p>Succinyl- CoA&nbsp; &rarr; Succinate</p>\n<p>&nbsp; &nbsp; &nbsp; ( 4C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&rarr; &nbsp; &nbsp; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme<strong>:&nbsp; Succinate Thiokinase</strong></p>\n<p>Cofactor: Mg<sup>2+</sup></p>\n<p>Release:&nbsp; 1 ATP / GTP</p>\n<p><strong>Substrate level phosphorylation</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 6</strong></td>\n</tr>\n<tr>\n<td>\n<p>Succinate&nbsp; &rarr;&nbsp;&nbsp; Fumarate</p>\n<p>( 4C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&rarr; &nbsp; &nbsp; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme:&nbsp; Succinate Dehydrogenase (Part of 2<sup>nd</sup> complex ETC)</p>\n<p>Cofactor:&nbsp; <strong>FAD and Fe-S protein</strong>&nbsp;</p>\n<p>The only enzyme of TCA cycle attached to the <strong>inner</strong> <strong>mitochondrial membrane.</strong></p>\n<p>Inhibited by:&nbsp;<strong>Malonate</strong>&nbsp;(<strong> competitive)</strong></p>\n<p>Release: FADH<sub>2</sub></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 7</strong></td>\n</tr>\n<tr>\n<td>\n<p>Fumarate&nbsp; &rarr;&nbsp;&nbsp; Malate</p>\n<p>( 4C &nbsp; &nbsp; &nbsp; &nbsp; &rarr; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme:&nbsp; Fumarate Hydratase</p>\n<p>Reaction: Hydration</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 8</strong></td>\n</tr>\n<tr>\n<td>\n<p>Malate&nbsp; &rarr;&nbsp; Oxaloacetate &nbsp;</p>\n<p>( 4C &nbsp; &nbsp; &rarr; &nbsp; &nbsp; &nbsp; &nbsp;4C )</p>\n<p>Enzyme:&nbsp; Malate Dehydrogenase</p>\n<p>Release:&nbsp; 1 NADH</p>\n<p>Oxaloacetate<strong> is</strong> <strong>regenerated.</strong></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/76825a8fa7b34db89430c4b5211dd573x1280x1018.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Energy production in TCA Cycle</h3><table>\n<tbody>\n<tr>\n<td><strong>Reaction</strong></td>\n<td><strong>&nbsp;Enzyme</strong></td>\n<td><strong>Method of ATP Generation</strong></td>\n<td><strong>Net ATP Produced</strong></td>\n</tr>\n<tr>\n<td>Isocitrate to alpha keto glutarate</td>\n<td>Isocitrate dehydrogenase</td>\n<td>From NADH</td>\n<td>1*2.5 ATP per NADH = 2.5 ATP</td>\n</tr>\n<tr>\n<td>Alpha keto glutarate to Succinyl CoA</td>\n<td>&alpha;-Ketoglutarate dehydrogenase complex</td>\n<td>From NADH</td>\n<td>1*2.5 ATP per NADH = 2.5 ATP</td>\n</tr>\n<tr>\n<td>Succinyl Co A to Succinate</td>\n<td>Succinate thiokinase</td>\n<td>GTP</td>\n<td>1GTP</td>\n</tr>\n<tr>\n<td>Succinate to fumarate</td>\n<td>Succinate dehydrogenase</td>\n<td>From FADH2</td>\n<td>1*1.5 ATP per FADH2 = 1.5 ATP</td>\n</tr>\n<tr>\n<td>Malate to Oxaloacetate</td>\n<td>Malate dehydrogenase</td>\n<td>From NADH</td>\n<td>1*2.5 ATP per NADH = 2.5 ATP</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td><strong>Total ATP produced per turn of the TCA</strong></td>\n<td>10 ATP</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5c84fa8060b14364b969378b7ed4aebf.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0021",
      "difficulty": "medium"
    },
    {
      "text": "Match the following eukaryotic DNA polymerases with their functions.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>DNA polymerase</strong></td>\n<td><strong>Function</strong></td>\n</tr>\n<tr>\n<td>1. Alpha</td>\n<td>A. Mitochondrial DNA synthesis</td>\n</tr>\n<tr>\n<td>2. Beta</td>\n<td>B.&nbsp;Primase</td>\n</tr>\n<tr>\n<td>3. Gamma</td>\n<td>C.&nbsp;DNA repair</td>\n</tr>\n<tr>\n<td>4. Delta</td>\n<td>D.&nbsp;Processive, leading strand synthesis</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>E.&nbsp;Processive, lagging strand synthesis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-A, 2-B, 3-C, 4-D"
        },
        {
          "id": 2,
          "text": "1-B, 2-C, 3-A, 4-E"
        },
        {
          "id": 3,
          "text": "1-C, 2-D, 3-E, 4-B"
        },
        {
          "id": 4,
          "text": "1- D, 2-A, 3-B, 4-C"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct match is<strong> 1-B, 2-C, 3-A, and 4-E.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>DNA polymerase</strong></td>\n<td><strong>Function</strong></td>\n</tr>\n<tr>\n<td>1. Alpha</td>\n<td>B. Primase</td>\n</tr>\n<tr>\n<td>2. Beta</td>\n<td>C.&nbsp;DNA repair</td>\n</tr>\n<tr>\n<td>3. Gamma</td>\n<td>A. Mitochondrial DNA synthesis</td>\n</tr>\n<tr>\n<td>4. Delta</td>\n<td>E.&nbsp;Processive, lagging strand synthesis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7f556b62fe574fe0ae33cf5fa1159019x980x1232.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Enzymes Involved in DNA Replication</h3><p>Prokaryotic DNA replication enzymes and their function:</p>\n<table>\n<tbody>\n<tr>\n<td>Enzyme</td>\n<td>Function</td>\n</tr>\n<tr>\n<td>DNA Polymerase I (Pol I)</td>\n<td>Gap filling following DNA replication, repair, and recombination</td>\n</tr>\n<tr>\n<td>DNA polymerase II (Pol II)</td>\n<td>DNA proofreading and repair</td>\n</tr>\n<tr>\n<td>DNA polymerase III (Pol III)</td>\n<td>\n<p>Processive, leading strand synthesis, DNA proofreading</p>\n</td>\n</tr>\n<tr>\n<td>DnaG</td>\n<td>\n<p>Primase&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Helicase</td>\n<td>ATP-driven processive unwinding of DNA.</td>\n</tr>\n<tr>\n<td>Primase</td>\n<td>Initiates synthesis of RNA primers.</td>\n</tr>\n<tr>\n<td>Topoisomerase</td>\n<td>Relieve torsional strain that results from helicase-induced unwinding.</td>\n</tr>\n<tr>\n<td>Single-strand binding proteins (SSBs)</td>\n<td>Prevents premature reannealing of dsDNA.</td>\n</tr>\n<tr>\n<td>DNA ligase</td>\n<td>Seals the single strand nick between the nascent chain and Okazaki fragments on lagging strand.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Eukaryotic DNA polymerases:</p>\n<table>\n<tbody>\n<tr>\n<td>Eukaryotic DNA Polymerases</td>\n<td>Functions</td>\n<td>Proofreading</td>\n</tr>\n<tr>\n<td>&alpha;&nbsp;</td>\n<td>Primase (initiates DNA synthesis)</td>\n<td>-</td>\n</tr>\n<tr>\n<td><em>&beta;</em></td>\n<td>DNA repair</td>\n<td>-</td>\n</tr>\n<tr>\n<td>\n<p>&gamma;</p>\n</td>\n<td>Mitochondrial DNA synthesis</td>\n<td>+</td>\n</tr>\n<tr>\n<td>&nbsp;&delta;&nbsp;</td>\n<td>Processive, lagging strand synthesis(forms and elongates Okazaki fragments from primer)</td>\n<td>+</td>\n</tr>\n<tr>\n<td>&nbsp;<em>&epsilon;&nbsp;</em></td>\n<td>Processive, leading strand synthesis</td>\n<td>+</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0665",
      "difficulty": "easy"
    },
    {
      "text": "You are a junior researcher studying about the properties of apoproteins.  Which of the following is the basis for the intestine-specific expression of apolipoprotein B-48?",
      "choices": [
        {
          "id": 1,
          "text": "DNA rearrangement and loss"
        },
        {
          "id": 2,
          "text": "DNA transposition"
        },
        {
          "id": 3,
          "text": "RNA alternative splicing"
        },
        {
          "id": 4,
          "text": "RNA editing"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The basis for the intestine-specific expression of <strong>apolipoprotein B-48</strong> is <strong>RNA editing.</strong></p>\n<p>The production of apolipoprotein <strong>(apo) B-48</strong> in the <strong>intestine</strong> and <strong>apoB-100</strong> in the <strong>liver</strong> is a result of <strong>RNA editing. </strong><span>The </span><strong>ApoB gene</strong><span> is </span><strong>transcribed </strong><span>into an</span><strong> mRNA</strong><span> that leads to the synthesis of </span><strong>100 kDa</strong><span> </span><strong>protein </strong><span>in the liver, which is called </span><strong>apoB100</strong><span>. </span><span>In the<strong> intestine</strong>, the same primary transcript is formed, but a<strong> cytidine deaminase</strong> converts a <strong>CAA codon</strong> in the mRNA <strong>into</strong> a <strong>UAA codon;</strong> thus codon for <strong>glutamine</strong> is <strong>changed</strong> to a <strong>termination codon</strong>. Thus<strong> 48kDa protein</strong> has resulted; this is <strong>apoB48.</strong></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4c3f9ca8abff4817950434dc4cafc5dbx720x558.JPEG\" alt=\"Explanation Image\"><p>DNA rearrangement, transposition and alternate splicing, do alter gene expression but are not the basis of apoB-48 tissue-specific production.</p><hr><h3>Related Pearl: Distribution of  Various Apolipoproteins on Lipoproteins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons remnants</p>\n</td>\n<td>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IDL</p>\n</td>\n<td>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL</p>\n</td>\n<td>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HDL</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre- &beta;- HDL</p>\n</td>\n<td>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Lipoprotein: Types, Sources and Action</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoproteins</strong></p>\n</td>\n<td>\n<p><strong>Source</strong></p>\n</td>\n<td>\n<p><strong>Action</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>Derived from intestinal absorption of triacylglycerol and other lipids</p>\n</td>\n<td>\n<p>Carry exogenous/dietary triacylglycerol from the intestine to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Very low density lipoproteins (VLDL)</p>\n</td>\n<td>\n<p>Derived from the liver</p>\n</td>\n<td>\n<p>Carry endogenous triacylglycerol from the liver to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low-density lipoproteins (LDL)</p>\n</td>\n<td>\n<p>Derived from VLDL</p>\n</td>\n<td>\n<p>Involved in cholesterol transport</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Highdensity lipoproteins (HDL)</p>\n</td>\n<td>\n<p>Derived from Liver, intestine, VLDL, chylomicrons</p>\n</td>\n<td>\n<p>Involved in reverse cholesterol &amp; Phospholipids transport and also in VLDL and chylomicron metabolism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Intermediate density lipoproteins(IDL)</p>\n</td>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>Triacylglycerol &amp; cholesterol transport</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0011",
      "difficulty": "medium"
    },
    {
      "text": "A child with severe acute malnutrition is undergoing nutritional rehabilitation. During follow-up visits, he shows significant improvement in appetite, an adequate gain of weight, and a gradual increase in subcutaneous body fat. Activity of which of the following enzymes is responsible for the restoration of fat storage in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Acetyl CoA carboxylase"
        },
        {
          "id": 2,
          "text": "Acyl-CoA dehydrogenase"
        },
        {
          "id": 3,
          "text": "Thiolase"
        },
        {
          "id": 4,
          "text": "Carnitine palmitoyl transferase - I"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>restoration </strong>of<strong> fat storage</strong> in a child undergoing nutritional rehabilitation, as evidenced by adequate weight gain and an increase in subcutaneous body fat, occurs with the help of <strong>acetyl CoA carboxylase.</strong></p>\n<p>With appropriate supplementation of nutrition, the child's body will gradually enter an <strong>anabolic phase. </strong>In the well fed state, there is an abundant supply of glucose, which is converted to pyruvate, which in turn is converted to acetyl CoA. <strong>Acetyl CoA</strong> is diverted into <strong>fatty acid synthesis</strong>, in which acetyl CoA carboxylase is the<strong> rate-limiting enzyme. </strong>There is also a high insulin : glucagon ratio in the well fed state. This favors dephosphorylation (activation) of acetyl CoA carboxylase, resulting in increased fatty acid synthesis. The fatty acids thus formed (most commonly palmitoyl CoA) are esterified into<strong> triacylglycerols</strong>. This process is called <strong>lipogenesis</strong>. </p>\n<p><strong>Note: </strong>The enzymes acyl-CoA dehydrogenase, thiolase, and carnitine palmitoyl transferase-I are involved in fatty acid oxidation and are inactive in the well-fed state. </p><hr><h3>Related Pearl: Enzymes active in phosphorylated and dephosphorylated state</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phosphorylated state</strong></p>\n<p>(Low insulin)</p>\n</td>\n<td>\n<p><strong>Dephosphorylated state</strong></p>\n<p>(High insulin)</p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Fructose 2,6 bisphosphatase</li>\n<li>PEP carboxykinase</li>\n<li>Pyruvate carboxylase</li>\n<li>Glycogen phosphorylase</li>\n<li>Hormone-sensitive lipase</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Phosphofructokinase</li>\n<li>Pyruvate dehydrogenase</li>\n<li>Glycogen synthase</li>\n<li>Acetyl CoA carboxylase</li>\n<li>HMG CoA reductase</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9938",
      "difficulty": "easy"
    },
    {
      "text": "What is the percentage of cytosine in DNA if the percentage of thymine residues is 28%?",
      "choices": [
        {
          "id": 1,
          "text": "22"
        },
        {
          "id": 2,
          "text": "28"
        },
        {
          "id": 3,
          "text": "36"
        },
        {
          "id": 4,
          "text": "44"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The percentage of <strong>cytosine</strong> in DNA will be <strong>22%.</strong></p>\n<p>According to <strong>Chargaff's rule</strong> in cellular DNA, regardless of species, <br />A = T and <span>G = C<br /></span><span>Purines = Pyrimidines i.e. <strong>A+G = C+T.</strong></span></p>\n<p>In the question it is given that thymine is 28%, therefore adenine is also 28%. So, adenine + thymine = 56% and guanine + cytosine = 44%. Since guanine = cytosine, the percentage of cytosine = 44/2 = 22%.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2380",
      "difficulty": "easy"
    },
    {
      "text": "What percentage of cellular DNA is in mitochondria?",
      "choices": [
        {
          "id": 1,
          "text": "1%"
        },
        {
          "id": 2,
          "text": "10%"
        },
        {
          "id": 3,
          "text": "0.1%"
        },
        {
          "id": 4,
          "text": "20%"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>1%</strong> of cellular DNA is in<strong> mitochondria. </strong></p>\n<p><strong>Human mitochondria</strong> contains 2 to 10 copies of a small <strong>circular</strong> ~16 kbp (kilo base pair) dsDNA molecule that makes up approximately<strong> 1%</strong> of <strong>total cellular DNA. </strong>Out of 37 genes in human mitochondrial DNA (mtDNA), 22 genes codes for transfer RNAs, 2 for ribosomal RNAs, and 13 for proteins that play key roles in the respiratory chain. A feature unique to human mitochondrial mtDNA is <strong>maternal non-mendelian inheritance</strong> because all mitochondria are contributed by the ovum during zygote formation. Thus, mothers transmit mtDNA to all their offspring.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/19f2ecb756d54bf8a0548c1880e4540cx1280x1035.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2390",
      "difficulty": "medium"
    },
    {
      "text": "A 14-year-old boy presented with fatigue, growth retardation, and neurologic abnormalities. Investigations revealed hemoglobin levels of 9 g/dL and orotic acid crystalluria. Peripheral blood smear showed a large number of hypochromic macrocytes. Other red cells were microcytic and hypochromic. Serum folate, B12 levels, and blood ammonia levels appeared normal. What is the most likely cause?",
      "choices": [
        {
          "id": 1,
          "text": "B12 metabolic defect"
        },
        {
          "id": 2,
          "text": "Urea cycle defect"
        },
        {
          "id": 3,
          "text": "Purine metabolism disorder"
        },
        {
          "id": 4,
          "text": "Pyrimidine metabolism disorder"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Hypochromic megaloblastic anemia with orotic acid crystalluria is consistent with <strong>orotic aciduria, </strong>a <strong>disorder of pyrimidine metabolism.</strong></p>\n<p>Orotic aciduria is a rare inborn error of metabolism. A defect in the enzyme uridine-5′-monophosphate (UMP) synthase in the <strong>pyrimidine synthesis pathway</strong> results in the failure of conversion of <strong>orotic acid</strong> to <strong>uridine</strong>. As a result, there is increased excretion of orotic acid in urine. The condition is characterized by <strong>hypochromic megaloblastic anemia</strong> that is <strong>unresponsive to vitamin B12 </strong>and <strong>folic acid</strong>, growth retardation, and neurologic abnormalities. Treatment includes,<strong> administration of uridine</strong> (100–200 mg/kg per day), which corrects anemia, reduces orotic acid excretion, and improves the other sequelae of the disorder.</p>\n<p><strong>Causes</strong> of<strong> megaloblastic anemia:-</strong></p>\n<ul>\n<li><strong>Cobalamin deficiency</strong>/abnormalities of cobalamin metabolism: malabsorption, absence of intrinsic factor, total/partial gastrectomy, ileal resection, Crohn's disease</li>\n<li><strong>Folate deficiency</strong>/ abnormalities of folate metabolism</li>\n<li>Therapy with <strong>antifolate drugs</strong> e.g., methotrexate</li>\n<li>Independent of cobalamin/folate deficiency:\n<ul>\n<li><strong>Acute myeloid leukemia,</strong> myelodysplasia</li>\n<li>Therapy with drugs interfering with the synthesis of DNA (e.g., cytosine arabinoside, hydroxyurea, 6-mercaptopurine)</li>\n<li><strong>Orotic</strong> <strong>aciduria</strong> (<strong>responds to uridine</strong>).</li>\n</ul>\n</li>\n</ul>\n<p>Other options:<br />Option (A): <strong>B12 metabolic defect </strong>is unlikely since B12 and folate levels are normal.<br />Option (B): <strong>Urea cycle defect</strong> is also unlikely because the blood ammonia levels are normal.<br />Option (C): <strong>Purine metabolism disorders</strong> include gouty arthritis, adenosine deaminase deficiency, and purine nucleoside phosphorylase deficiency.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/531f8bac777a4976915d2195bb353662x1280x1588.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Morphological Classification of Anemias</h3><p> </p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Microcytic Hypochromic </strong></p>\n<p><strong>(MCV &lt;80 fl)</strong></p>\n</td>\n<td>\n<p><strong>Normocytic Normochromic    </strong></p>\n<p><strong>(MCV 80 - 100 fl)</strong></p>\n</td>\n<td>\n<p><strong>Macrocytic Normochromic </strong></p>\n<p><strong>(MCV &gt;100 fl)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron deficiency anemia</p>\n<p>Sideroblastic anemia</p>\n<p>Thalassemia</p>\n<p>Lead toxicity</p>\n</td>\n<td>\n<p>Acute blood loss</p>\n<p>Anemia of chronic disease</p>\n<p>Anemia of renal disease</p>\n<p>Hemolysis*</p>\n<p>Bone marrow suppression</p>\n<ul>\n<li>Aplastic anemia</li>\n<li>Pure red cell aplasia</li>\n</ul>\n<p> </p>\n<p>  </p>\n</td>\n<td>\n<p><strong>Megaloblastic:</strong></p>\n<p>Vitamin B12 deficiency</p>\n<p>Folate deficiency</p>\n<p>Thiamine deficiency</p>\n<p>Drugs - Methotrexate, Zidovudine, hydroxyurea</p>\n<p>Orotic aciduria</p>\n<p> </p>\n<p><strong>Non-megaloblastic:</strong></p>\n<p>Alcohol use</p>\n<p>Liver disease</p>\n<p>Hypothyroidism</p>\n<p>Hemolysis*</p>\n<p> </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Hemolysis can be associated with macrocytosis because of compensatory reticulocytosis. However, MCV can be normal depending on the degree of hemolysis.</p>\n<p>Note: In Orotic Aciduria, peripheral blood smear shows Hypochromic megaloblastic anemia. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0276",
      "difficulty": "medium"
    },
    {
      "text": "The catalytic efficiency of enzyme is best expressed by which of the following kinetic constants:",
      "choices": [
        {
          "id": 1,
          "text": "Kcat/Km"
        },
        {
          "id": 2,
          "text": "Km/Kcat"
        },
        {
          "id": 3,
          "text": "Km/Ka"
        },
        {
          "id": 4,
          "text": "Ka/Km"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">The<strong> catalytic efficiency</strong> of an enzyme is expressed as </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>K<sub>cat</sub>/K<sub>m</sub>.</strong></span></p>\n<p><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>K<sub>cat </sub></strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is the </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>rate </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>constant</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">, which is the <strong>limiting rate</strong> of an enzyme-catalyzed reaction at<strong> saturation. </strong>It is given by V<sub>max</sub> divided by number of active sites of the enzyme. </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>K<sub>m </sub></strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is the </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Michaelis</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">-</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Menten </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>constant</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">, which is defined as the substrate concentration at which the initial velocity</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(V<sub>i</sub>) </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is half the maximum velocity </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">V<sub>max</sub>/2).</span></p>\n<p><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">For some enzymes, when a substrate </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(S) </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">binds to the active site of the enzyme </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(E),</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> and forms an enzyme-substrate complex </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(ES),</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> the product is instantaneously formed. </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">For such enzymes, the reaction of E+S→ES becomes the <strong>rate-limiting step. </strong>Its rate is determined on the rate of diffusion of the molecules in a solution. Hence, these enzymes are called </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>diffusion</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">-</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>limited </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">or </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>catalytically </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>perfect</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">.</span></p>\n<p><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Examples of the catalytically perfect enzymes, where the catalytic efficiency </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">reaches the<strong> diffusion</strong> <strong>limit</strong> of 10<sup>8</sup>-10<sup>9</sup> M<sup>−1</sup>s<sup>−1</sup>:</span></p>\n<ul class=\"listtype-bullet listindent1 list-bullet1\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Triosephosphate isomerase</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Carbonic anhydrase</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Acetylcholinesterase</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Adenosine deaminase</span></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7670",
      "difficulty": "medium"
    },
    {
      "text": "A 9-year-old boy was brought with complaints of a fishy smell in his hands, feet, saliva, and urine. A urinalysis revealed the substance responsible for the odor, and a diagnosis of Fish odor syndrome was made. Which is the substance responsible for this characteristic body odor?",
      "choices": [
        {
          "id": 1,
          "text": "Trimethylamine-N-oxide"
        },
        {
          "id": 2,
          "text": "Trimethylamine"
        },
        {
          "id": 3,
          "text": "Flavin monooxygenase"
        },
        {
          "id": 4,
          "text": "Choline"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the given clinical scenario of <strong>fish odor syndrome</strong>, the characteristic odor is due to <strong>trimethylamine (TMA)</strong>, which is released in sweat, urine, and breath.</p>\n<p><strong>Fish odor syndrome</strong> (trimethylaminuria) is an autosomal recessive disease. It is due to a deficiency of <strong>flavin-containing monooxygenase 3 (FMO3)</strong> which converts the amino acid, TMA (trimethylamine) to TMA-N-oxide (which is non-odorous) in the liver. <strong>TMA</strong> thus builds up in the body and is released in sweat, urine, and breath, giving off a strong <strong>odor</strong> of <strong>rotting</strong> <strong>fish</strong> from the body.</p>\n<p>Patients present in <strong>childhood</strong> or early adulthood with <strong>halitosis</strong> or <strong>body odor </strong>(distinctive fishy odor). Patients suffer from <strong>psychosocial problems</strong> such as shame, anxiety, depression, etc. Diagnosis is based on high levels of excreted trimethylamine (TMA) in the patient's urine. </p>\n<p>Treatment involves <strong>avoiding foods</strong> containing choline such as egg, liver, peas, and soy products. A <strong>short course of antibiotics</strong> such as neomycin and metronidazole can be given which reduce the production of trimethylamine by the gut bacteria.</p><hr><h3>Related Pearl: Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0671",
      "difficulty": "medium"
    },
    {
      "text": "You are a researcher studying the mechanism of action of statins which inhibit the enzyme HMG-CoA reductase by acting as a structural analog to its natural substrate. The Lineweaver Burk Plot for the interaction is given below. Which of the following is true about this type of inhibition?",
      "choices": [
        {
          "id": 1,
          "text": "Vmax of the reaction increases"
        },
        {
          "id": 2,
          "text": "Vmax of the reaction decreases"
        },
        {
          "id": 3,
          "text": "Km of the reaction increases"
        },
        {
          "id": 4,
          "text": "Km of the reaction decreases"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given example of statin inhibiting cholesterol synthesis by acting on HMG-CoA reductase and the graph is a type of <strong>competitive inhibition.</strong> True about competitive inhibition is that the <strong>K<sub>m</sub></strong> of the<strong> reaction increases.</strong></p>\n<p>Important parameters in a reaction include:</p>\n<ul>\n<li>The affinity of the enzyme for its substrate is given by the<strong> Michaelis constant </strong>or <strong>K<sub>m</sub></strong><strong>. </strong>A <strong>low K<sub>m</sub></strong> reflects a <strong>high affinity</strong> of the <strong>enzyme</strong> for substrate and vice versa. The value of Km is given by the substrate concentration at which the reaction velocity is equal to one-half V<sub>max</sub>. It does not change with changes in enzyme concentration. </li>\n<li>The <strong>rate</strong> of the<strong> reaction</strong> is directly <strong>proportional</strong> to the <strong>enzyme concentration.</strong></li>\n</ul>\n<p><strong>Competitive inhibition </strong>is when the inhibitor binds reversibly to the substrate-binding site and competes with the substrate for the active enzyme binding site.</p>\n<p>This effect of competitive inhibition can be overcome by increasing the substrate concentration by which maximum velocity can still be achieved. Therefore, <strong>V<sub>max</sub></strong> is <strong>unaltered</strong> in this type of inhibition. However, the concentration of the substrate required to achieve half of the maximum velocity is increased. Therefore, <strong>K<sub>m</sub></strong> is <strong>increased</strong> in this condition.</p>\n<p><strong>Noncompetitive inhibition </strong>is by <strong>binding</strong> of inhibitors to enzymes in locations<strong> remote</strong> from the active <strong>site.</strong> Increasing the concentration of the substrate does not overcome non-competitive inhibition. Thus, noncompetitive inhibitors <strong>decrease </strong>the<strong> V<sub>max</sub></strong> of the reaction. They do not interfere with the binding of the substrate to the enzyme. Thus, the enzyme shows the<strong> same K<sub>m</sub></strong> in the presence or absence of noncompetitive inhibitors.</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>Graph showing the changes in V<sub>max</sub> and K<sub>m</sub> in competitive and noncompetitive inhibition.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b2d1c8cc6956485ab5d1c4109e670023x1280x2317.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ffd327a25fb045959c699d4ffb05e602x1280x2235.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Difference between Reversible and Irreversible Inhibitors</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Reversible Inhibitors</strong></p>\n</td>\n<td>\n<p><strong>Irreversible Inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Binds via non-covalent interaction</p>\n</td>\n<td>\n<p>Binds via covalent interactions</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>No chemical change</p>\n</td>\n<td>\n<p>Inhibitor binds to the substrate &amp; prevent catalytic activity of enzymes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Can be reversed, as there is no bonding between the inhibitor &amp; substrate</p>\n</td>\n<td>\n<p>Irreversibility due to strong covalent bonding</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Difference between Competitive & Non-Competitive inhibitors</h3><p>Reversible inhibitors are of two types:</p>\n<ul>\n<li>Competitive inhibitors</li>\n<li>Non-Competitive inhibitors</li>\n</ul>\n<p>Difference between Competitive &amp; Non-Competitive inhibitors</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Competitive inhibitors</strong></p>\n</td>\n<td>\n<p><strong>Non-Competitive inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Succinate dehydrogenase is inhibited by Malonate</p>\n</td>\n<td>\n<p>Pyruvate kinase is inhibited by alanine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Substrate &amp; inhibitor are chemically similar &amp; have same shape</p>\n</td>\n<td>\n<p>Substrate &amp; inhibitor are chemically not similar &amp; have different shape</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor binds to active site</p>\n</td>\n<td>\n<p>Inhibitor binds away from active site, i.e., at allosteric site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor does not change the shape of the active site</p>\n</td>\n<td>\n<p>Inhibitor changes the shape of the active site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Increase in substrate concentration reduces the inhibition</p>\n</td>\n<td>\n<p>Increase in substrate concentration does not affect the inhibition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vmax remains constant</p>\n</td>\n<td>\n<p>Vmax decreases</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Km Increases</p>\n</td>\n<td>\n<p>Km remains constant</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0b7c647c969d4c03b617bf8d7cd88c9b.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0381",
      "difficulty": "easy"
    },
    {
      "text": "Which among the following sentences about collagen is false?",
      "choices": [
        {
          "id": 1,
          "text": "Collagen has a triple helical structure, forming a right-handed superhelix"
        },
        {
          "id": 2,
          "text": "Proline and hydroxyproline confer rigidity to collagen"
        },
        {
          "id": 3,
          "text": "Enzyme lysyl oxidase is defective in Menkes disease which contains copper as a cofactor "
        },
        {
          "id": 4,
          "text": "Marfan syndrome is due to mutation in gene encoding collagen"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the following sentences about collagen, the false statement is (option D). <strong>Marfan syndrome</strong> is due to a mutation in the gene encoding <strong>fibrillin-1</strong> (not collagen).</p>\n<p>Collagen is the most abundant protein in the animal world. It has a <strong>triple helica</strong>l structure, forming a <strong>right-handed superhelix</strong>. A striking characteristic of collagen is the occurrence of <strong>glycine residues</strong> at <strong>every third position.</strong></p>\n<p><strong>Proline </strong>and<strong> hydroxyproline</strong> confer<strong> rigidity</strong> on the collagen molecule. Hydroxyproline and hydroxylysine are formed by the <strong>post-translational hydroxylation</strong> of proline and lysine residues catalyzed by the enzyme prolyl and lysyl hydroxylase, whose cofactors are<strong> ascorbic acid (vitamin C) and α-ketoglutarate.</strong></p>\n<p>Collagen is arranged in a <strong>quarter-staggered arrangemen</strong>t and further stabilized by covalent cross-links.</p>\n<p><strong>Menke disease </strong>is a <strong>progressive neurodegenerative</strong> condition with an<strong> X-linked recessive </strong>pattern of inheritance. It's caused by a <strong>defect</strong> in the<strong> ATP7A gene</strong>, leading to <strong>impaired intestinal copper absorption </strong>and <strong>transport, </strong>resulting in<strong> low serum copper </strong>and <strong>ceruloplasmin levels</strong>. This affects the <strong>cross-linking </strong>o<strong>f collagen </strong>by<strong> lysyl oxidase</strong>, which requires<strong> copper </strong>as a <strong>cofactor</strong>, leading to <strong>defective connective tissue formation.</strong></p><hr><h3>Related Pearl: Synthesis of collagen and its disorders</h3><table>\n<tbody>\n<tr>\n<td>1. Collagen backbone</td>\n<td>Preprocollagen - Glycin-proline-lysine</td>\n</tr>\n<tr>\n<td>2. Hydroxylation</td>\n<td>\n<p>Of proline and lysine in the presence of Vit C.</p>\n<p>Deficiency of Vit C causes <strong>Scurvy.</strong></p>\n</td>\n</tr>\n<tr>\n<td>3. Glycosylation</td>\n<td>Formation of procollagen and resulting triple helix</td>\n</tr>\n<tr>\n<td>4. Cleavage of terminals of procollagen</td>\n<td>Resulting in the formation of tropocollagen</td>\n</tr>\n<tr>\n<td>5. Cross-linking by lysyl oxidase (copper-containing enzyme)</td>\n<td>\n<p>Formation of mature collagen.</p>\n<p>Defect causes <strong>Menkes disease</strong> and <strong>Ehlers-Danlos syndrome</strong>)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD1873",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following chromatography techniques is correctly matched with its property used for separation?",
      "choices": [
        {
          "id": 1,
          "text": "Hydrophobic interaction chromatography - selectivity for ligands"
        },
        {
          "id": 2,
          "text": "Gel filtration chromatography - Stokes radii"
        },
        {
          "id": 3,
          "text": "Ion exchange chromatography -  interactions with hydrophobic groups"
        },
        {
          "id": 4,
          "text": "Affinity chromatography -  charge-charge interactions"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\"><strong>Gel filtration chromatography, </strong>also known as<strong> size exclusion chromatography </strong>separates proteins on the basis of their <strong>Stokes radii.&nbsp;</strong>Stokes radius is a measure of the effective volume a protein occupies in<span class=\"Apple-converted-space\">&nbsp;a free solution. It accounts for both the mass and the shape of the protein.&nbsp;</span></p>\n<p class=\"p1\"><span class=\"Apple-converted-space\">The correctly matched chromatography techniques are:</span></p>\n<ul>\n<li class=\"p1\"><span class=\"Apple-converted-space\">Hydrophobic interaction chromatography - Interactions with hydrophobic groups</span></li>\n<li class=\"p1\"><span class=\"Apple-converted-space\">Gel filtration chromatography - Stokes radii</span></li>\n<li class=\"p1\"><span class=\"Apple-converted-space\"><span class=\"Apple-converted-space\">Ion exchange chromatography -&nbsp;Charge-charge interactions</span></span></li>\n<li class=\"p1\"><span class=\"Apple-converted-space\"><span class=\"Apple-converted-space\">Affinity chromatography -&nbsp;Selectivity for ligands&nbsp;</span></span></li>\n</ul>\n<div class=\"page\" title=\"Page 36\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Types of Chromatography:</p>\n<p><strong>1. Gel filtration chromatography: </strong>Proteins with large and small <strong>stokes radii</strong> are applied to the top of a gel filtration column. On entering the column, the small proteins enter pores in the stationary phase matrix (included proteins). During the mobile phase flowing down the column, they lag behind the large molecules, which get excluded (excluded proteins). Proteins thus emerge from a gel filtration column in descending order of their Stokes radii.</p>\n</div>\n</div>\n</div>\n</div>\n<p class=\"p1\">&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e32581fb2af9442680b6255a0f530b1ax1280x1780.JPEG\" alt=\"Explanation Image\"><p class=\"p1\">&nbsp;<strong>2. Ion exchange chromatography: </strong>Proteins interact with the stationary phase by <strong>charge-charge interactions.</strong> Proteins with a net positive charge at a given pH will tightly adhere to negatively charged beads called cation exchangers. Proteins with a net negative charge will adhere to positively charged beads called anion exchangers. Nonadherent proteins flow through the matrix and are washed away.</p>\n<p class=\"p1\">Bound proteins are then selectively displaced by weakening charge-charge interactions. This is done by&nbsp;gradually raising the ionic strength of the mobile phase. It is shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1cd1b504289c473a88db580afe92049dx315x382.JPEG\" alt=\"Explanation Image\"><p><strong>3. Affinity chromatography</strong> is based on the&nbsp;<strong>high selectivity</strong> displayed by most proteins for their <strong>ligands. </strong>Enzymes are purified using immobilized substrates, products, coenzymes, or inhibitors. In theory, only proteins that interact with the immobilized ligand adhere. Bound proteins are then eluted either by competition with a free, soluble ligand or by disrupting protein-ligand interactions. It is shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1a0474ac3b3e4c9c92efea8d131d4115x782x489.JPEG\" alt=\"Explanation Image\"><p><strong>4. Hydrophobic interaction chromatography</strong>&nbsp;separates proteins based on their tendency to associate with a stationary phase matrix coated with <strong>hydrophobic groups</strong>. Proteins with exposed hydrophobic surfaces adhere to the matrix via hydrophobic bonds that are enhanced by employing a mobile phase of high ionic strength.&nbsp;</p><hr><h3>Related Pearl: Types of Chromatography</h3><table>\n<tbody>\n<tr>\n<td><strong>Chromatography types</strong></td>\n<td><strong>Property used for separation</strong></td>\n</tr>\n<tr>\n<td>Paper chromatography</td>\n<td>Based on <strong>polarity</strong>, <strong>Least polar</strong> moves <strong>faster</strong></td>\n</tr>\n<tr>\n<td>Thin layer chromatography</td>\n<td>Based on <strong>polarity</strong>, <strong>Least polar</strong> moves <strong>faster</strong></td>\n</tr>\n<tr>\n<td>Ion exchange chromatography</td>\n<td>Based on <strong>charge &ndash; charge</strong> interaction</td>\n</tr>\n<tr>\n<td>Size exclusion chromatography</td>\n<td>Based on <strong>descending order</strong> of <strong>Stokes radius</strong> which is a function of <strong>molecular mass and shape</strong></td>\n</tr>\n<tr>\n<td>Affinity chromatography</td>\n<td>Based on <strong>specific ligand binding</strong> behaviour</td>\n</tr>\n<tr>\n<td>Hydrophobic interaction chromatography</td>\n<td>Based on <strong>hydrophobic </strong>interaction</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0750",
      "difficulty": "hard"
    },
    {
      "text": "An undernourished child is brought for consultation. You prescribe a mineral supplement that is absorbed by the mechanism shown in the image below. Identify the supplement.",
      "choices": [
        {
          "id": 1,
          "text": "Copper"
        },
        {
          "id": 2,
          "text": "Iron"
        },
        {
          "id": 3,
          "text": "Calcium"
        },
        {
          "id": 4,
          "text": "Zinc"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows <strong>iron absorption and transport</strong> from a duodenal enterocyte into the blood, hence the mineral supplement prescribed can be identified as an <strong>iron</strong> supplement.</p>\n<p>The following image shows in detail, the absorption of iron from a duodenal enterocyte.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/434650ea843645ec80e4a24389d0209dx1280x1210.JPEG\" alt=\"Explanation Image\"><p>Dietary iron is available in two forms - heme and non-heme iron. Initially, the ferric <strong>non-heme iron</strong> is <strong>reduced</strong> to ferrous iron by <strong>duodenal cytochrome B (ferric reductase)</strong>&nbsp;or by <strong>vitamin C</strong>.<strong>&nbsp;</strong>The reduced ferrous iron is then transferred into the enterocyte by <strong>DMT 1 (divalent metal transporter)</strong>.&nbsp;</p>\n<p>Heme iron moves into the cytoplasm with the help of transporters. Here, it is metabolized to release ferrous iron, which then follows the same pathway as non-heme iron.</p>\n<p>Once inside the enterocyte, it can <strong>either</strong> get <strong>stored as ferritin</strong> or <strong>transferred</strong> across the basolateral membrane<strong> by ferroportin.</strong>&nbsp;In the <strong>plasma</strong>, iron is transported in the <strong>Fe<sup>3+</sup> form bound to transferrin</strong>, which is a transport protein. Hephaestin is a ferroxidase that oxidizes Fe<sup>2+</sup> to Fe<sup>3+</sup> before it is transported.</p>\n<p><strong>Hepcidin</strong>, a protein secreted from the liver plays a major role in the regulation of iron absorption. When the body&rsquo;s iron stores are adequate it downregulates the expression of <strong>ferroportin</strong> and thereby iron absorption too. Thus,<strong> iron is trapped</strong> in the intestinal cells which is eventually sloughed off. Hepcidin also <strong>inhibits</strong> the release of <strong>iron from macrophages</strong> by binding to ferroportin.&nbsp;High hepcidin levels are seen in systemic inflammation and low hepcidin levels are seen in hemochromatosis.</p>\n<p><strong>Iron</strong> is an important <strong>component</strong> of</p>\n<ul>\n<li>Hemoglobin</li>\n<li>Myoglobin</li>\n<li>Cytochrome P450 groups of enzymes</li>\n<li>Components of the electron transport chain</li>\n<li>Ribonucleotide reductase</li>\n</ul><hr><h3>Related Pearl: Factors affecting iron absorption</h3><p><strong>Enhancers:</strong></p>\n<ul>\n<li>Ascorbic acid</li>\n<li>Citric acid</li>\n<li>Amino acid</li>\n<li>Sugars in the diet</li>\n</ul>\n<p><strong>Inhibitors:</strong></p>\n<ul>\n<li>Tannins</li>\n<li>Carbonate</li>\n<li>Oxalate</li>\n<li>Phosphate</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/45ea55be372e490c8d03a381df054d76.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0514",
      "difficulty": "easy"
    }
  ]
}